Vorinostat (SAHA)

目录号：S1047 别名： MK0683

Molecular Weight(MW): 264.3

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。

规格

价格

库存

购买数量

10mM/1mL In DMSO	RMB 1558.77	现货
200mg	RMB 1198.15	现货
500mg	RMB 1794.86	现货
大包装	有超大折扣

大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck该产品发表文献267篇：

Cell, 2019, 176(1-2):198-212

PubMed: 30503211 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Cell, 2018, 174(3):536-548.e21

PubMed: 29961578 ( click the link to review the publication )

Nature, 2017, 551(7679):247-250

PubMed: 29088702 ( click the link to review the publication )

Cancer Discov, 2017, 7(12):1450-1463

PubMed: 28963352 ( click the link to review the publication )

Cancer Cell, 2016, 29(3):311-323

PubMed: 26977882 ( click the link to review the publication )

Nat Biotechnol, 2015, 10.1038/nbt.3130

PubMed: 25751058 ( click the link to review the publication )

Nat Med, 2015, 21(10):1163-71

PubMed: 26390243 ( click the link to review the publication )

Nat Med, 2015, 10.1038/nm.3855

PubMed: 25939062 ( click the link to review the publication )

Cell, 2014, 158(5):989-99

PubMed: 25131989 ( click the link to review the publication )

Nature, 2011, 471(7337):235-9

PubMed: 21390130 ( click the link to review the publication )

Nat Biotechnol, 2011, 29(3):255-65

PubMed: 21258344 ( click the link to review the publication )

Nat Commun, 2019, 10(1):4192

PubMed: 31519896 ( click the link to review the publication )

J Pineal Res, 2019, 66(3):e12556

PubMed: 30648757 ( click the link to review the publication )

Haematologica, 2019, 10.3324/haematol.2018.211110

PubMed: 30846494 ( click the link to review the publication )

Haematologica, 2019, 104(11):2225-2240

PubMed: 30819918 ( click the link to review the publication )

Theranostics, 2019, 9(2):540-553

PubMed: 30809292 ( click the link to review the publication )

Cancer Res, 2019, 79(7):1658-1670

PubMed: 30737231 ( click the link to review the publication )

Cell Rep, 2019, 27(11):3331-3344

PubMed: 31189115 ( click the link to review the publication )

Elife, 2019, 8

PubMed: 30652970 ( click the link to review the publication )

Mol Ther, 2019, 27(5):1039-1050

PubMed: 30852137 ( click the link to review the publication )

Mol Ther, 2019, 27(5):1039-1050

PubMed: 30852137 ( click the link to review the publication )

Cancers (Basel), 2019, 11(4)

PubMed: 30935067 ( click the link to review the publication )
Clin Epigenetics, 2019, 11(1):85

PubMed: 31142371 ( click the link to review the publication )

Acta Pharm Sin B, 2019, 9(5):937-951

PubMed: 31649844 ( click the link to review the publication )

Cells, 2019, 8(12)

PubMed: 31795298 ( click the link to review the publication )

Cancer Discov, 2019, 9(4):526-545

PubMed: 30709805 ( click the link to review the publication )

Front Immunol, 2019, 9:3162

PubMed: 30723480 ( click the link to review the publication )

Mol Cancer Ther, 2019, 18(5):900-908

PubMed: 30824609 ( click the link to review the publication )

Mol Oncol, 2019, 10.1002/1878-0261.12607

PubMed: 31782885 ( click the link to review the publication )

Epigenetics, 2019, 10.1080/15592294.2019.1656155

PubMed: 31423895 ( click the link to review the publication )

Epigenetics, 2019, 14(8):791-803

PubMed: 31088315 ( click the link to review the publication )

Epigenetics, 2019, 10.1080/15592294.2019.1656156

PubMed: 31423932 ( click the link to review the publication )

AIDS, 2019, 33(2):199-209

PubMed: 30562171 ( click the link to review the publication )

Hum Mol Genet, 2019, 10.1093/hmg/ddz254

PubMed: 31691806 ( click the link to review the publication )

Pharmacol Res, 2019, 139:524-534

PubMed: 30366100 ( click the link to review the publication )

Pharmacol Res, 2019, 146:104281

PubMed: 31125601 ( click the link to review the publication )

Mol Pharm, 2019, 16(9):3904-3915

PubMed: 31318566 ( click the link to review the publication )

Bone, 2019, 125:112-121

PubMed: 31100533 ( click the link to review the publication )

Front Cell Neurosci, 2019, 13:468

PubMed: 31708743 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(13)

PubMed: 31269745 ( click the link to review the publication )

Apoptosis, 2019, 24(5-6):404-413

PubMed: 30997620 ( click the link to review the publication )

J Biol Chem, 2019, 294(12):4437-4449

PubMed: 30670592 ( click the link to review the publication )

Acta Pharmacol Sin, 2019, 40(5):677-688

PubMed: 30224636 ( click the link to review the publication )

NMR Biomed, 2019, 32(2):e4044

PubMed: 30561869 ( click the link to review the publication )

Stem Cells Dev, 2019, 28(7):438-453

PubMed: 30667343 ( click the link to review the publication )

Chem Biol Interact, 2019, 306:54-61

PubMed: 30958996 ( click the link to review the publication )
Gene Ther, 2019, 26(3-4):75-85

PubMed: 30538307 ( click the link to review the publication )

Cancer Med, 2019, 8(14):6383-6392

PubMed: 31456359 ( click the link to review the publication )

Tuberculosis (Edinb), 2019, 118:101861

PubMed: 31526947 ( click the link to review the publication )

PLoS One, 2019, 14(6):e0218382

PubMed: 31206526 ( click the link to review the publication )

Exp Hematol, 2019, 72:60-71

PubMed: 30769020 ( click the link to review the publication )

Nucl Med Biol, 2019, 74-75:1-11

PubMed: 31421440 ( click the link to review the publication )

Alcohol, 2019, 78:79-87

PubMed: 30851364 ( click the link to review the publication )

Anticancer Res, 2019, 39(7):3579-3584

PubMed: 31262882 ( click the link to review the publication )

Res Vet Sci, 2019, 126:207-212

PubMed: 31610471 ( click the link to review the publication )

Exp Ther Med, 2019, 17(6):4547-4553

PubMed: 31186678 ( click the link to review the publication )

Medicina (Kaunas), 2019, 55(2)

PubMed: 30700046 ( click the link to review the publication )

Cell Host Microbe, 2018, 24(5):689-702

PubMed: 30344003 ( click the link to review the publication )

Sci Adv, 2018, 4(9):eaar4666

PubMed: 30263952 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(16):3941-3954

PubMed: 29764852 ( click the link to review the publication )

Cancer Res, 2018, 78(10):2705-2720

PubMed: 29490948 ( click the link to review the publication )

J Control Release, 2018, 275:117-128

PubMed: 29474960 ( click the link to review the publication )

Haematologica, 2018, 103(4):679-687

PubMed: 29305415 ( click the link to review the publication )

J Hematol Oncol, 2018, 11(1):32

PubMed: 29486795 ( click the link to review the publication )

Cancer Lett, 2018, 432:121-131

PubMed: 29890207 ( click the link to review the publication )

Sci Signal, 2018, 11(557)

PubMed: 30459282 ( click the link to review the publication )

J Exp Clin Cancer Res, 2018, 37(1):153

PubMed: 30012171 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(12):2767-2779

PubMed: 30232145 ( click the link to review the publication )

J Virol, 2018, 92(10)

PubMed: 29343578 ( click the link to review the publication )

Sci Rep, 2018, 8(1):3521

PubMed: 29476067 ( click the link to review the publication )
J Cell Biochem, 2018, 119(5):4193-4204

PubMed: 29274289 ( click the link to review the publication )

Retrovirology, 2018, 15(1):36

PubMed: 29751762 ( click the link to review the publication )

Exp Cell Res, 2018, 371(1):231-237

PubMed: 30107147 ( click the link to review the publication )

BMC Cancer, 2018, 18(1):466

PubMed: 29695239 ( click the link to review the publication )

Alcohol Clin Exp Res, 2018, 42(11):2160-2171

PubMed: 30103280 ( click the link to review the publication )

Oncol Rep, 2018, 39(1):264-270

PubMed: 29115632 ( click the link to review the publication )

Ann Hematol, 2018, 97(5):839-849

PubMed: 29359239 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 498(3):481-486

PubMed: 29505792 ( click the link to review the publication )

AAPS PharmSciTech, 2018, 19(2):634-647

PubMed: 28948528 ( click the link to review the publication )

Cell Biochem Funct, 2018, 36(8):398-407

PubMed: 30484863 ( click the link to review the publication )

Cell Host Microbe, 2017, 21(5):569-579

PubMed: 28494238 ( click the link to review the publication )

Nat Struct Mol Biol, 2017, 24(1):47-54

PubMed: 27870832 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3139-3149

PubMed: 27986747 ( click the link to review the publication )

Haematologica, 2017, 102(4):736-745

PubMed: 27979926 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3084-3096

PubMed: 27993968 ( click the link to review the publication )

Oncogene, 2017, 36(34):4859-4874

PubMed: 28414307 ( click the link to review the publication )

Br J Pharmacol, 2017, 174(20):3608-3622

PubMed: 28749535 ( click the link to review the publication )

Eur J Med Chem, 2017, 127:531-553

PubMed: 28109947 ( click the link to review the publication )

Cancer Sci, 2017, 108(7):1485-1492

PubMed: 28498513 ( click the link to review the publication )

Int J Mol Sci, 2017, 18(5)

PubMed: 28481295 ( click the link to review the publication )

J Biol Chem, 2017, 292(12):5043-5054

PubMed: 28167529 ( click the link to review the publication )

J Pharmacol Exp Ther, 2017, 363(2):211-220

PubMed: 28860353 ( click the link to review the publication )

Pharm Res, 2017, 34(3):668-679

PubMed: 28101809 ( click the link to review the publication )

Cancer Med, 2017, 6(11):2673-2685

PubMed: 29024573 ( click the link to review the publication )
Int J Cell Biol, 2017, 2017:6169310

PubMed: 28321257 ( click the link to review the publication )

Connect Tissue Res, 2017, 58(1):64-75

PubMed: 27404795 ( click the link to review the publication )

Pulm Pharmacol Ther, 2017, 44:88-95

PubMed: 28323055 ( click the link to review the publication )

Am J Surg, 2017, 213(4):645-651

PubMed: 28007318 ( click the link to review the publication )

Oncotarget, 2017, 9(1):512-523

PubMed: 29416632 ( click the link to review the publication )

Oncotarget, 2017, 8(31):51429-51446

PubMed: 28881658 ( click the link to review the publication )

Oncotarget, 2017, 8(31):51429-51446

PubMed: 28881658 ( click the link to review the publication )

CPT Pharmacometrics Syst Pharmacol, 2017, 6(11):756-764

PubMed: 29045072 ( click the link to review the publication )

Sci Rep, 2017, 7(1):2290

PubMed: 28536458 ( click the link to review the publication )

Oncotarget, 2017, 8(45):78480-78495

PubMed: 29108243 ( click the link to review the publication )

JCI Insight, 2017, 2(1):e85811

PubMed: 28097226 ( click the link to review the publication )

JCI Insight, 2017, 2(6):e90196

PubMed: 28352655 ( click the link to review the publication )

Oncotarget, 2017, 8(28):45687-45697

PubMed: 28537899 ( click the link to review the publication )

Oncotarget, 2017, 10.18632/oncotarget.15017

PubMed: 28157715 ( click the link to review the publication )

Oncotarget, 2017, 8(44):77254-77267

PubMed: 29100385 ( click the link to review the publication )

Ann Oncol, 2016, 27(3):508-13

PubMed: 26658891 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

Cancer Res, 2016, 76(23):7001-7011

PubMed: 27671680 ( click the link to review the publication )

Cancer Res, 2016, 76(8):2376-83

PubMed: 26941288 ( click the link to review the publication )

Int J Cancer, 2016, 139(1):194-204

PubMed: 26914605 ( click the link to review the publication )

Drug Discov Today, 2016, 21(9):1553-1560

PubMed: 27371506 ( click the link to review the publication )

J Med Chem, 2016, 59(4):1613-33

PubMed: 26681404 ( click the link to review the publication )

Mol Cancer Ther, 2016, 15(6):1364-75

PubMed: 27196750 ( click the link to review the publication )

Mol Cell Proteomics, 2016, 15(6):2076-92

PubMed: 27067055 ( click the link to review the publication )
Neuropharmacology, 2016, 107:111-121

PubMed: 26970016 ( click the link to review the publication )

Biochem Pharmacol, 2016, 102:130-140

PubMed: 26718586 ( click the link to review the publication )

Am J Pathol, 2016, 186(10):2701-8

PubMed: 27555113 ( click the link to review the publication )

J Biol Chem, 2016, 291(19):10131-47

PubMed: 27022024 ( click the link to review the publication )

Neurochem Int, 2016, 96:24-31

PubMed: 27103167 ( click the link to review the publication )

Int J Oncol, 2016, 49(6):2453-2463

PubMed: 27748897 ( click the link to review the publication )

Am J Physiol Heart Circ Physiol, 2016, 311(5):H1139-H1149

PubMed: 27638876 ( click the link to review the publication )

Cancer Biol Ther, 2016, 17(1):27-35

PubMed: 26575826 ( click the link to review the publication )

Anal Bioanal Chem, 2016, 408(13):3547-53

PubMed: 26968571 ( click the link to review the publication )

BMC Cancer, 2016, 16:667

PubMed: 27549189 ( click the link to review the publication )

J Hum Genet, 2016, 10.1038/jhg.2016.61

PubMed: 27251006 ( click the link to review the publication )

J Hum Genet, 2016, 10.1038/jhg.2016.61

PubMed: 27251006 ( click the link to review the publication )

Med Oncol, 2016, 33(2):11

PubMed: 26732474 ( click the link to review the publication )

Inflammation, 2016, 39(1):39-46

PubMed: 26228975 ( click the link to review the publication )

PLoS One, 2016, 11(1):e0145985

PubMed: 26726879 ( click the link to review the publication )

Onco Targets Ther, 2016, 9:6843-6855

PubMed: 27877053 ( click the link to review the publication )

Leuk Lymphoma, 2016, 57(3):692-9

PubMed: 26084206 ( click the link to review the publication )

Asian Pac J Trop Med, 2016, 9(6):572-6

PubMed: 27262069 ( click the link to review the publication )

Genet Mol Res, 2016, 15(4)

PubMed: 27819724 ( click the link to review the publication )

Oncotarget, 2016, 7(36):58142-58147

PubMed: 27494885 ( click the link to review the publication )

Sci Rep, 2016, 6:21678

PubMed: 26902929 ( click the link to review the publication )

Oncotarget, 2016, 7(6):6727-47

PubMed: 26734995 ( click the link to review the publication )

Nat Commun, 2015, 6:7888

PubMed: 26223951 ( click the link to review the publication )

EMBO Mol Med, 2015, 10.15252/emmm.201404396

PubMed: 25872941 ( click the link to review the publication )
EMBO Mol Med, 2015, 10.15252/emmm.201404580

PubMed: 25759362 ( click the link to review the publication )

Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-14-2701

PubMed: 25813020 ( click the link to review the publication )

Clin Cancer Res, 2015, 21(7):1628-38

PubMed: 25623213 ( click the link to review the publication )

Blood Cancer J, 2015, 5:e312

PubMed: 25978432 ( click the link to review the publication )

Int J Cancer, 2015, 136(11):2717-29

PubMed: ( click the link to review the publication )

Cancer Lett, 2015, 356(2 Pt B):828-36

PubMed: 25449774 ( click the link to review the publication )

Cancer Lett, 2015, 366(1):32-43

PubMed: 26028172 ( click the link to review the publication )

Breast Cancer Res, 2015, 17:33

PubMed: 25888415 ( click the link to review the publication )

Cell Death Dis, 2015, 6:e1657

PubMed: 25695609 ( click the link to review the publication )

Circ Heart Fail, 2015, 8(6):1094-104

PubMed: 26371176 ( click the link to review the publication )

Acta Neuropathol Commun, 2015, 3(1):22

PubMed: 25853389 ( click the link to review the publication )

Endocr Relat Cancer, 2015, 22(5):777-92

PubMed: 26206775 ( click the link to review the publication )

Br J Haematol, 2015, 168(3):371-83

PubMed: ( click the link to review the publication )

Epigenetics, 2015, 10.1080/15592294.2015.1039216

PubMed: 25923331 ( click the link to review the publication )

Am J Cancer Res, 2015, 5(4):1337-52

PubMed: 26101701 ( click the link to review the publication )

Neuropharmacology, 2015, 99:67-78

PubMed: 26188143 ( click the link to review the publication )

Biochemical Pharmacology, 2015, 94(2):79-90

PubMed: ( click the link to review the publication )

Biochem Pharmacol, 2015, 94(2):79-90

PubMed: 25600908 ( click the link to review the publication )

Biochemical Pharmacology, 2015, 94(2):79-90

PubMed: ( click the link to review the publication )

Apoptosis, 2015, 20(7):975-85

PubMed: 25835755 ( click the link to review the publication )

J Biol Chem, 2015, 290(8):5028-40

PubMed: 25540204 ( click the link to review the publication )

J Biol Chem, 2015, 290(39):23725-37

PubMed: 26269591 ( click the link to review the publication )

J Biol Chem, 2015, 290(3):1829-36

PubMed: 25492871 ( click the link to review the publication )

J Biol Chem, 2015, 290(8):5028-40

PubMed: ( click the link to review the publication )
BMC Cancer, 2015, 15(1):273

PubMed: 25880212 ( click the link to review the publication )

FEBS Lett, 2015, 589(10):1080-8

PubMed: 25816750 ( click the link to review the publication )

J Biotechnol, 2015, 10.1016/j.jbiotec.2015.02.029

PubMed: 25746901 ( click the link to review the publication )

Mol Med Rep, 2015, 12(3):4291-4297

PubMed: 26095064 ( click the link to review the publication )

Oncotarget, 2015, 6(18):15814-27

PubMed: 26158412 ( click the link to review the publication )

Sci Transl Med, 2014, 6(256):256ra135

PubMed: 25273096 ( click the link to review the publication )

Acta Neuropathol, 2014, 128(2):291-303

PubMed: 24839957 ( click the link to review the publication )

Nat Commun, 2014, 5:3361

PubMed: 24553445 ( click the link to review the publication )

Clin Cancer Res, 2014, 10.1158/1078-0432.CCR-14-0384

PubMed: 25355930 ( click the link to review the publication )

Int J Cancer, 2014, 135(7):1721-32

PubMed: 24615207 ( click the link to review the publication )

Diabetes, 2014, 63(9):2924-34

PubMed: 24722245 ( click the link to review the publication )

Oncogene, 2014, 33(25):3307-15

PubMed: 23995789 ( click the link to review the publication )

Cancer Lett, 2014, 10.1016/j.canlet.2014.10.034

PubMed: ( click the link to review the publication )

Cancer Lett, 2014, 351(1):50-8

PubMed: 24814395 ( click the link to review the publication )

PLoS Pathog, 2014, 10(4):e1004071

PubMed: 24722454 ( click the link to review the publication )

PLoS Pathog, 2014, 10(4):e1004071

PubMed: 24722454 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1134

PubMed: 24651437 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1177

PubMed: 24743732 ( click the link to review the publication )

Mol Cancer Ther, 2014, 13(12):2784-92

PubMed: 25319394 ( click the link to review the publication )

J Mol Biol, 2014, 426(20):3442-53

PubMed: 24657767 ( click the link to review the publication )

Hum Gene Ther, 2014, 25(7):599-608

PubMed: 24568341 ( click the link to review the publication )

J Biol Chem, 2014, 289(14):9918-25

PubMed: 24515107 ( click the link to review the publication )

Cancer Cell Int, 2014, 10.1186/s12935-014-0112-x

PubMed: ( click the link to review the publication )

Cancer Cell Int, 2014, 14(1):112

PubMed: 25546354 ( click the link to review the publication )
Mol Cell Biol, 2014, 34(7):1280-9

PubMed: 24469401 ( click the link to review the publication )

Proteomics Clin Appl, 2014, 8(11-12):924-31

PubMed: 25091122 ( click the link to review the publication )

J Alzheimers Dis, 2014, 41(4):1193-205

PubMed: 24844691 ( click the link to review the publication )

Cancer Biol Ther, 2014, 15(5):578-85

PubMed: 24556916 ( click the link to review the publication )

BMC Cancer, 2014, 14(1):373

PubMed: 24886166 ( click the link to review the publication )

FEBS Lett, 2014, 588(9):1571-9

PubMed: 24607544 ( click the link to review the publication )

Mol Med Rep, 2014, 10(5):2729-35

PubMed: 25199623 ( click the link to review the publication )

Oncol Lett, 2014, 7(5):1673-1678

PubMed: 24765199 ( click the link to review the publication )

Pharmacol Res Perspect, 2014, 2(3):e00043

PubMed: 25505589 ( click the link to review the publication )

Head Neck, 2014, 10.1002/hed.23822.

PubMed: 24986420 ( click the link to review the publication )

Cytometry A, 2014, 85(1):78-87

PubMed: 24038859 ( click the link to review the publication )

Curr Pharm Desigh, 2014, 20(11):1874-80

PubMed: 23888956 ( click the link to review the publication )

Pharmacology Research Perspectives, 2014, 10.1002/prp2.43

PubMed: ( click the link to review the publication )

Oncotarget, 2014, 5(15):5965-77

PubMed: 25115389 ( click the link to review the publication )

Blood, 2013, 123(5):706-16

PubMed: 24319254 ( click the link to review the publication )

Nat Struct Mol Biol, 2013, 20(3):317-25

PubMed: 23377543 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2013, 111(3):E364-73

PubMed: 24395801 ( click the link to review the publication )

PLoS Biol, 2013, 12(1):e1001758

PubMed: 24409098 ( click the link to review the publication )

Cancer Res, 2013, 73(8):2428-34

PubMed: 23382048 ( click the link to review the publication )

Cell Rep, 2013, 5(6):1679-89

PubMed: 24360956 ( click the link to review the publication )

Int J Cancer, 2013, 132(9):2200-8

PubMed: 23024001 ( click the link to review the publication )

Neuropsychopharmacology, 2013, 38(9):1674-84

PubMed: 23474591 ( click the link to review the publication )

Oncogene, 2013, 33(33):4265-72

PubMed: 24292675 ( click the link to review the publication )

Oncogene, 2013, 32(10):1316-29

PubMed: 22543582 ( click the link to review the publication )
Cell Death Dis, 2013, 4:e655

PubMed: 23744355 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e733

PubMed: 23868066 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e951

PubMed: 24309938 ( click the link to review the publication )

Br J Haematol, 2013, 160(2):188-98

PubMed: 23167276 ( click the link to review the publication )

AIDS, 2013, 27(18):2853-62

PubMed: 24189584 ( click the link to review the publication )

J Biol Chem, 2013, 288(35):25593-602

PubMed: 23878197 ( click the link to review the publication )

J Biol Chem, 2013, 288(20):14400-7

PubMed: 23539624 ( click the link to review the publication )

PLoS Comput Biol, 2013, 9(2):e1002887

PubMed: 23408876 ( click the link to review the publication )

Mol Carcinog, 2013, 52(3):218-28

PubMed: 22121107 ( click the link to review the publication )

Front Pharmacol, 2013, 4:44

PubMed: 23596417 ( click the link to review the publication )

Genes Brain Behav, 2013, 13(1):69-86

PubMed: 24286462 ( click the link to review the publication )

Cell Cycle, 2013, 12(13):2073-83

PubMed: 23759592 ( click the link to review the publication )

PLoS One, 2013, 8(6):e66130

PubMed: 23762475 ( click the link to review the publication )

PLoS One, 2013, 8(1):e53766

PubMed: 23320102 ( click the link to review the publication )

J Thromb Thrombolysis, 2013, 35(2):185-92

PubMed: 23229086 ( click the link to review the publication )

J Exp Med, 2012, 209(1):35-50

PubMed: 22231305 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(14):3822-33

PubMed: 22623731 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(2):408-16

PubMed: 22038994 ( click the link to review the publication )

Cancer Res, 2012, 72(9):2251-61

PubMed: 22422937 ( click the link to review the publication )

Cell Death Differ, 2012, 19(12):2029-39

PubMed: 22858545 ( click the link to review the publication )

Cell Death Differ, 2012, 19(8):1317-27

PubMed: 22322857 ( click the link to review the publication )

Eur J Cancer, 2012, 48(7):1096-107

PubMed: 22154545 ( click the link to review the publication )

Diabetologia, 2012, 55(9):2421-31

PubMed: 22772764 ( click the link to review the publication )

FASEB J, 2012, 26(7):3032-41

PubMed: 22459148 ( click the link to review the publication )
J Neurochem, 2012, 123 Suppl 2:108-15

PubMed: 23050648 ( click the link to review the publication )

J Leukoc Biol, 2012, 91(5):701-9

PubMed: 22028329 ( click the link to review the publication )

J Biol Chem, 2012, 287(43):36609

PubMed: 22952229 ( click the link to review the publication )

Mol Carcinog, 2012, 52(6):459-74

PubMed: 22308110 ( click the link to review the publication )

Invest New Drugs, 2012, 30(2):541-7

PubMed: 21107885 ( click the link to review the publication )

Pharm Res, 2012, 29(7):1960-76

PubMed: 22415140 ( click the link to review the publication )

Oncol Rep, 2012, 28(1):105-10

PubMed: 22484732 ( click the link to review the publication )

PLoS One, 2012, 7(9):e44265

PubMed: 22957056 ( click the link to review the publication )

PLoS One, 2012, 7(12):e52335

PubMed: 23272238 ( click the link to review the publication )

PLoS One, 2012, 7(12):e52753

PubMed: 23300762 ( click the link to review the publication )

Chronobiol Int, 2012, 29(8):982-93

PubMed: 22891617 ( click the link to review the publication )

Biochem Biophys Res Co, 2012, 420(2):325-30

PubMed: 22425986 ( click the link to review the publication )

Pediatr Surg Int, 2012, 28(6):579-89

PubMed: 22526548 ( click the link to review the publication )

Protein Expr Purif, 2012, 86(1):45-52

PubMed: 21992606 ( click the link to review the publication )

Brain, 2011, 134(Pt 8):2408-21

PubMed: 21772061 ( click the link to review the publication )

Clin Cancer Res, 2011, 17(9):2819-29

PubMed: 21357681 ( click the link to review the publication )

Clin Cancer Res, 2011, 17(16):5311-21

PubMed: 21724551 ( click the link to review the publication )

Genes Dev, 2011, 25(24):2610-8

PubMed: 22016339 ( click the link to review the publication )

J Neurosci, 2011, 31(11):3990-9

PubMed: 21411642 ( click the link to review the publication )

J Transl Med, 2011, 9:37

PubMed: 21477288 ( click the link to review the publication )

Retrovirology, 2011, 2(3):411-23

PubMed: 21966324 ( click the link to review the publication )

Mol Med, 2011, 17(5-6):466-72

PubMed: 21424110 ( click the link to review the publication )

PLoS One, 2011, 6(7):e22739

PubMed: 21818379 ( click the link to review the publication )

BMC Neurosci, 2011, 12:50

PubMed: 21615950 ( click the link to review the publication )
Sci Signal, 2010, 3(146):ra80

PubMed: 21045206 ( click the link to review the publication )

J Pharmacol Exp Ther, 2010, 86(16):8765-72

PubMed: 20739454 ( click the link to review the publication )

Exp Dermatol, 2010, 19(12):1096-102

PubMed: 20629733 ( click the link to review the publication )

产品安全说明书

HDAC抑制剂选择性比较

生物活性

产品描述

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。

特性

Vorinostat是广谱HDAC活性抑制剂，抑制I和II类酶。

靶点

HDAC ^[1]
(Cell-free assay)

~10 nM

体外研究

Vorinostat是小分子量（<300）线性肟酸，抑制HDAC活性，包括乙酰化组蛋白和非组蛋白的积累，抑制培养细胞的增殖，且抑制肿瘤生长。Vorinostat通过结合到酶的活性位点而抑制 HDAC活性。Vorinostat 抑制多种转化细胞增殖（包括淋巴瘤，多发性骨髓瘤，白血病，和非小细胞肺癌），与对照组相比抑制生长达50% 时的浓度为0.5 到10μM。Vorinostat作用于淋巴瘤和白血病细胞，包括 Burkitt, B-细胞急性淋巴细胞白血病 (B-ALL), MCL, DLBCL, ATL和T-细胞，不同程度抑制细胞增殖。除了抑制转化细胞增殖, Vorinostat 也抑制正常细胞增殖，通过比较Vorinostat 作用于一组细胞系–正常人非纤维细胞(WI-38)和 SV40巨大T抗原转化WI-38(VA-13细胞)而得到证明。Vorinostat 抑制两种类型细胞增殖，这种作用存在剂量依赖性。但发现Vorinostat 对转化细胞具有选择毒性，包括使肿瘤细胞死亡，而对正常细胞只起抑制作用，不会使其死亡。^[1] Genistein 和Vorinostat 联用效果比5-aza和Vorinostat 联用作用于诱导细胞死亡有效很多。Genistein和Vorinostat联用作用于ARCaP-E使增殖降低 80 %，作用于ARCaP-M细胞，增殖降低60 %以上。Genistein和Vorinostat 联用抑制细胞增殖具有协同效应。作用于ARCaP-E 细胞(820个基因诱导和1046个基因抑制) ARCaP-M 细胞，Vorinostat比Genistein 影响更多基因。^[2] Vorinostat作用于肿瘤细胞表面，提高Fas蛋白水平，这种作用存在剂量依赖性，且按0.75 μM剂量处理，提高达到一个稳定水平。^[3] Vorinostat 抑制肿瘤细胞生长，包括NB4, H460 和HCT-116，IC50分别为0.7μM, 3.4μM和1.2 μM。^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
A20	MnfjT4lv[XOnIFHzd4F6		MmS0NUBp	NXnyVI5DTE2VTx?=	NVP6bJRC[W62aT3ISGFEOSCjY4Tpeol1gSC5aYToJGlEPTBib3[gNE4yOTJizszN	MkW2NVE6PjB2OEm=
Friend leukemic cell	NWm1SJZtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NUfafIRwPTBizszN	MkW3O\|IhcA>?	MluySG1UVw>?	MUXJR\|UxRTBwOUmg{txO	MnzpNVIyODl7MUO=
K562	MXTLbY5ie2ViQYPzZZk>		Mnz2OkBp	NXe2fmRyTE2VTx?=	NVnVTFBuUW6qaXLpeIlwdiCxZjDoeY1idiCqaYP0c45mKGSnYXPleJlt[XOnIDjtbZh1fXKnIH;mJGhFSUNzIHHu[EBJTEGFMjmge4l1cCCLQ{WwJI9nKDBwMEGg{txO	M{HV[\|EzPDF7M{iw
HT1080	NHTsTohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFXKSm44OiCq	M4TkOGROW09?	M3v3[GlEPTB;Mj60JO69VQ>?	NW\nbGl5OTJ{N{CxO\|U>
H1299	NX\a[4V1U2mwYYPlJGF{e2G7		NH;nRWQzOCCvaX6=	NYrM[YFwTE2VTx?=	MYDJcohq[mm2b4L5JIFkfGm4aYT5JIFo[Wmwc4SgTGRCSyCnbor5cYUhf2m2aDDJR\|UxKG:oIECuNVk1KM7:TR?=	NUfCeGx1OTR3MkG0NlI>
H1299	NVzDfYZVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NX\xdJJUPzJiaB?=	NHi1eoxFVVOR	MmThTWM2OD15LkK0JO69VQ>?	M4Ls[lE1PTJzNEKy
HeLa	Ml3oT4lv[XOnIFHzd4F6		MXmzNEBucW5?		M4TiUmlvcGmkaYTvdpkh[2:wY3XueJJifGmxbjDh[4FqdnO2IHjpd5RwdmViZHXhZ4V1gWyjc3Wge4l1cCCLQ{WwJI9nKDBwMkig{txO	MnTjNVU3ODN7NEm=
LOX-IMVI	NVPDbZRoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Ml7vOFghcA>?		MkGyTWM2OD1zLkOg{txO	MUCxOVcyPTR5MB?=
NCI-H226	NVnOdmd{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MWS0PEBp		MmnXTWM2OD1{Lk[g{txO	MYWxOVcyPTR5MB?=
RXF-631L	NFewN5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{S5XFQ5KGh?		NIHMcHhKSzVyPUKg{txO	NXT4b\|JvOTV5MUW0O\|A>
SNB-78	NWjBb5NlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NV;lb4V3PDhiaB?=		MX;JR\|UxRTF4IN88US=>	MnfZNVU4OTV2N{C=
St-4	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M1PKelQ5KGh?		M13ZTmlEPTB;NT6yJO69VQ>?	NIH6dYoyPTdzNUS3NC=>
ARP1	MlTkSpVv[3Srb36gRZN{[Xl?	MoW4NkDPxE1?	MU[2JIg>		NYfaNZhNUW6mdXP0bY9vKG:oIGCyNXdCTjFiZ3Xu[UBmgHC{ZYPzbY9v	NYrQbYVJOTR5M{S4NFY>
CEM	NWHsPGNOU2mwYYPlJGF{e2G7		MVixJIg>	M{T3R2ROW09?	NWXUbYlHUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlM{KM7:TR?=	MYixOlQzODB4NB?=
HCT15	NIfibJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MYe0PEBp		MXfHTVUxRTBwOEKg{txO	NVvxUWVtOTZ5MkOyNlc>
NCI-H23	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MoHtOFghcA>?		M{jhOmdKPTB;MD65NkDPxE1?	MX6xOlczOzJ{Nx?=
GM15850	NHvsXJRMcW6jc3WgRZN{[Xl?	Ml7nNk42KM7:TR?=	NHfiUFU6PiCq	NFrMbYVFVVOR	M3n3OWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFizJIx6e2mwZTCxOEBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	NYTZZ3lZOTZ7MkGzOlc>
GM15850	Mmr2T4lv[XOnIFHzd4F6	M{jHRVIvPSEQvF2=	MUO5OkBp	NF74dJBFVVOR	NUXNOGFEUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm\|aX7lJFUh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	M1vVdlE3QTJzM{[3
GM15850	MoXrT4lv[XOnIFHzd4F6	NWPQWGxCOi53IN88US=>	NYPBWXBLQTZiaB?=	MWrEUXNQ	M4jFVWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFi0JIx6e2mwZTCxNkBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	NV7PRWE3OTZ7MkGzOlc>
GM15850	M4fndGtqdmG\|ZTDBd5NigQ>?	NWSybY9UOi53IN88US=>	NIfGXXY6PiCq	NIrl[G5FVVOR	M37YRWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFizJIx6e2mwZTC5JIFk\XS7bHH0bY9vKG:oIF\YUkBo\W6n	NULLVG9JOTZ7MkGzOlc>
GM15850	NV7LRWVDU2mwYYPlJGF{e2G7	MlXVNk42KM7:TR?=	MYK5OkBp	MWfEUXNQ	NWHNN2lZUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm\|aX7lJFgh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	M2rzelE3QTJzM{[3
GM15850	NV7WW\|l2U2mwYYPlJGF{e2G7	NVe4NnJXOi53IN88US=>	M3zUTlk3KGh?	NID4fpVFVVOR	MWHJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKNDDsfZNqdmViMU[gZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV?	Mlz3NVY6OjF\|Nke=
U937	MXvGeY5kfGmxbjDBd5NigQ>?	NWrueVlDPSEQvF2=	NUDxR2FDOjRiaB?=	NYr3VJZiTE2VTx?=	MV\D[YxtKGO7Y3zlJIFzemW\|dDDifUBi[2O3bYXsZZRqd25iYYSgV{9IOi:PIIDoZZNm	MXWxO\|AxPDdzOB?=
H661	NVTaOocyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NETpfXk1QCCq		NVvUXoNRUUN3ME2xJO69VQ>?	MVWxO\|E2PzByOR?=
U937	NH3mS4lHfW6ldHnvckBCe3OjeR?=	M1jF[\|Uh\|ryP	NVi1V5doOjRiaB?=	NHTjSIdFVVOR	M3zHSGlv[3KnYYPlJIlvKGirc4TvcoUhUDNiYXPleJlt[XSrb36=	MnWwNVc1PDd5NUC=
U937	M{\aVWZ2dmO2aX;uJGF{e2G7	MnHYNUDPxE1?	MmnSNlQhcA>?	NG\LNotFVVOR	NUmxc3pPTW[oZXP0JI9vKGGucHjhJJR2[nWuaX6gZYNmfHmuYYTpc44>	MWqxO\|Q1Pzd3MB?=
RAW264.7	MofMSpVv[3Srb36gRZN{[Xl?	MnfFNVAh\|ryP	MVWyOIg>	MYf3ZZRmeg>?	NWDXR2xYUW6qaXLpeIlwdiCxZjDMVHMue3SrbYXsZZRm\CCWTl\hcJBp[SCycn;keYN1cW:wIIfpeIghUUN3MDDv[kAxNjd4IN88US=>	NW\tOpVbOTd2N{e1NVg>
RAW264.7	NHHLfHJHfW6ldHnvckBCe3OjeR?=	NFfOfZEyOCEQvF2=	NVrMZYlqOjSq	NV;yVllCf2G2ZYK=	MYjJcohq[mm2aX;uJI9nKEySUz3zeIlufWyjdHXkJG5QKHC{b3T1Z5Rqd25id3n0bEBKSzVyIH;mJFEvQDhizszN	NH;vNFEyPzR5N{WxPC=>
SC9	NYn1cFFPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVTRfHFXPDhiaB?=		NGqzdI5KSzVyPUCuOlA3KM7:TR?=	MUOxO\|UxPzJzOR?=
ST14A	MV;GeY5kfGmxbjDBd5NigQ>?	NX7qN4dqPSCwTR?=	Mn73O\|IhcA>?		NWjkPXExUW6lcnXhd4UhcW5iUlXTWE9PWlOIIH3SUmEh\XiycnXzd4lwdg>?	NVvLcI9VOTd3NkW5PVM>
ST14A	NWjITnk6TnWwY4Tpc44hSXO\|YYm=	NVfXOY9qPSCwTR?=	MnGwO\|IhcA>?		NH2zWpJKdmO{ZXHz[UBqdiCHMl[xJI1TVkFiZYjwdoV{e2mxbh?=	MoHyNVc2PjV7OUO=
PANC1	M2HXNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NEPTTGMyKM7:TR?=			M3r6S2lEPTB;MD60OUDPxE1?	NIDaO\|UyPzV6OEe0OC=>
PANC1	MUDGeY5kfGmxbjDBd5NigQ>?	NYXaN4I{OSEQvF2=	M1fOdVI1KGh?		NULPbYtuUW6lcnXhd4UhcW5icEKxW2FHOS:FSWCxJIdmdmViZYjwdoV{e2mxbh?=	M4ntd\|E4PTh6N{S0
PANC1	NEKweZhHfW6ldHnvckBCe3OjeR?=	MWCxJO69VQ>?	NEfBU20zPCCq		NUjwOXVXUW6lcnXhd4UhcW5icEK3b4lxOSCpZX7lJIV5eHKnc4Ppc44>	NWTqS3R5OTd3OEi3OFQ>
PT45	NFLTVlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYLWPIhDUUN3ME20JO69VQ>?	NHH0fWMyPzV6OEe0OC=>
ACHN	NHftc4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NIfWdJQzOSCq		MVHHTVUxRTBwNkWg{txO	NEjV[YkyPzZ4Mk[wOi=>
PC3	MlHuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NGX0U\|kzOSCq		MWLHTVUxRTBwN{Gg{txO	MliyNVc3PjJ4ME[=
A431	M4TaNGN6fG:2b4jpZ{BCe3OjeR?=		MmO4O\|IhcA>?		NFn0b\|FKSzVyPUSuNkDPxE1?	NVHoNJZWOTd4OUG3OlM>
Cal27	NXfQVVJsS3m2b4TvfIlkKEG\|c3H5		NHvMclc4OiCq		NEHyRVNKSzVyPUOuNkDPxE1?	NYfid4tFOTd4OUG3OlM>
CCRF-CEM	NVPTbVBZS3m2b4TvfIlkKEG\|c3H5		M{DlPFczKGh?		NHThcpJKSzVyPUCuPEDPxE1?	NYq5Z3ZOOTd4OUG3OlM>
EOL1	NH33No9EgXSxdH;4bYMhSXO\|YYm=		NV3Fe4g6PzJiaB?=		MkL5TWM2OD1zIN88US=>	NIrBNmMyPzZ7MUe2Ny=>
Hec-1-A	M2\BeGN6fG:2b4jpZ{BCe3OjeR?=		MXS3NkBp		Ml7UTWM2OD1zIN88US=>	NXTLbVEyOTd4OUG3OlM>
HeLa	NGq5N4VMcW6jc3WgRZN{[Xl?	M3y3c\|ExKM7:TR?=	M{TGXVMxKG2rbh?=	NV3ibZdNTE2VTx?=	NHj2c5BKdmirYnn0bY9vKG:oIILlZ49u[mmwYX70JGhFSUNzIIfpeIghUUN3MDDv[kAxNjB{IN88US=>	MlvpNVc3QTF5NkO=
RKOp21	M1vxZmN6fG:2b4jpZ{BCe3OjeR?=		M1PHXVczKGh?		MV;JR\|UxRTFwN{[g{txO	Mk\mNVc3QTF5NkO=
Saos2	M1znemN6fG:2b4jpZ{BCe3OjeR?=		M3HnW\|czKGh?		Mo[1TWM2OD1{LkOg{txO	MUmxO\|Y6OTd4Mx?=
SK-OV-3	MVfDfZRwfG:6aXOgRZN{[Xl?		M1zVVVczKGh?		NFr1cIFKSzVyPUKuNkDPxE1?	NUHn[2F7OTd4OUG3OlM>
U87MG	NUT6S3g{S3m2b4TvfIlkKEG\|c3H5		M4qx[FczKGh?		MWHJR\|UxRTFzIN88US=>	MorqNVc3QTF5NkO=
NUGC3	M3PrdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NWjEO2QyPSEQvF2=	M1vkd\|I1KGh?		NVruXIhsT0l3ME2yMlc6KM7:TR?=	NIHxPJoyPzlyNEi0Ny=>
CCD1059SK	MnHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIrlNoJKSzVyPUSzMlUh\|ryP	MX6xPFI1PzV3NB?=
HepG2	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{n2Z2lEPTB;MD6wNFA3KM7:TR?=	NUHFcWtQOTh{NEe1OVQ>
HT1080	NWe1bnRlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3rRU2lEPTB;MD6wNFI1KM7:TR?=	MXexPFI1PzV3NB?=
SKBR3	NYTjO4ZuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVvJR\|UxRTBwODFOwG0>	Ml\QNVgzPDd3NUS=
SNB78	MnHvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4TuSmVEPTB;MU[g{txO	Ml\2NVgzPDd3NUS=
SQ20B	NE[2UVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUDtVmZbUUN3ME2zJO69VQ>?	MWCxPFI1PzV3NB?=
St4	NV7VcGN3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3;MbmVEPTB;NT6yJO69VQ>?	NGjNeJIyQDJ2N{W1OC=>
MCF7	MoTESpVv[3Srb36gRZN{[Xl?	MkCxNVAh\|ryP	NX7NW2RjQCCq	NUm5V5ZmTE2VTx?=	MWXJcoR2[3Srb36gc4YhfHWkdXzpckBpgXCncnHj[ZR6dGG2aX;u	NX;r[YNVOTh{NkmyNlY>
HEK293	NIfudodMcW6jc3WgRZN{[Xl?		NU\iXHdZOSCq	MWHEUXNQ	M4P3U2lvcGmkaYTpc44hd2ZiSFTBR\|Ehf2m2aDDJR\|UxKG:oIECuNFMh\|ryP	Mo\UNVg{ODh3NkO=
HEK293	M2HnSmtqdmG\|ZTDBd5NigQ>?		Ml7hNUBp	M4DMWmROW09?	MVPJcohq[mm2aX;uJI9nKEiGQVOzJJdqfGhiSVO1NEBw\iByLkC1O{DPxE1?	MlLkNVg{ODh3NkO=
G401	MoPkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		Moj4O\|IhcA>?	NYLXN5A5TE2VTx?=	MkLlTWM2OD1zIN88US=>	NXr6[mlYOTh\|N{CzO\|M>
HeLa	NGP0dmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NFn6SYE4OiCq	NX[4cmpNTE2VTx?=	MWrJR\|UxRTBwNE[g{txO	MXGxPFM4ODN5Mx?=
Human renal epithelial cell	NFPBR\|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUW3NkBp	NIrFcmRFVVOR	M1TMSmlEPTB;MUSg{txO	NWjuUnpWOTh\|N{CzO\|M>
U937	M4TWSWZ2dmO2aX;uJGF{e2G7	MmrpOUDPxE1?	MVOyOEBp		NFrWfIxKdmS3Y4Tpc44hd2ZiaHnzeI9v\SCKNDDofZBmemGlZYT5cIF1cW:w	NGPLNIUyQDN6MUKzPC=>
U937	MlPNSpVv[3Srb36gRZN{[Xl?	NXLaXG9[PSEQvF2=	NXjid25GOjRiaB?=		Mm\DTY5lfWO2aX;uJI9nKGGucHjhJJR2[nWuaX6gbJlx\XKjY3X0fYxifGmxbh?=	MUCxPFM5OTJ\|OB?=
U937	MYjGeY5kfGmxbjDBd5NigQ>?	NV\0VYJ2PSEQvF2=	MlvBNlQhcA>?		MULJcoR2[3Srb36gc4YheDJzIHX4dJJme3Orb36=	MX2xPFM5OTJ\|OB?=
U937	MXHGeY5kfGmxbjDBd5NigQ>?	NUOzZXQzPSEQvF2=	MXmyOEBp		MnnOTY5lfWO2aX;uJI9nKGGyb4D0c5Nqew>?	NVTyc2lzOTh\|OEGyN\|g>
U937	NGDBbFRHfW6ldHnvckBCe3OjeR?=	MkfhOUDPxE1?	NVzxW4l[OjRiaB?=		MX;JcoR2[3Srb36gc4Yh\3KjboXsc4N6fGmlIHTp[oZmemWwdHnheIlwdg>?	M4TxZVE5OzhzMkO4
U937	NYXjd2xOU2mwYYPlJGF{e2G7	MVS1JO69VQ>?	M3jENFI1KGh?		MnXOTY5pcWKrdHnvckBw\iCqdX3hckBJTEGFMR?=	NXfSXJhYOTh\|OEGyN\|g>
U937	NFK4PXpMcW6jc3WgRZN{[Xl?	NGfRNJI2KM7:TR?=	M4LvPFI1KGh?		NWrCRlBoUW6qaXLpeIlwdiCxZjDoeY1idiCKRFHDOC=>	MYixPFM5OTJ\|OB?=
HEK-TE	M3[xO2Z2dmO2aX;uJGF{e2G7	MnP0OUDPxE1?	MknjOog>	MU\EUXNQ	MmLDTY5kemWjc3WgbY4hcGm\|dH;u[UBJOyCjY3X0fYxifGmxbh?=	MX2xPFQ{PDF2NB?=
HPDE6c7	MlzuR5l1d3SxeHnjJGF{e2G7	NYK3UYlSPTBizszN	Ml7nO\|IhcA>?	M2PO[2ROW09?	NULnT2djUUN3ME2xMlMh\|ryP	NWD2NHl5OTh2OUS0OlM>
Human microvascular epithelial cell	MV\DfZRwfG:6aXOgRZN{[Xl?	M3jHTVUxKM7:TR?=	M3:yTFczKGh?	MX7EUXNQ	MkTKTWM2OD1zLkOg{txO	MlzMNVg1QTR2NkO=
Hup T3	MnrmR5l1d3SxeHnjJGF{e2G7	NF3zVXc2OCEQvF2=	M3zXW\|czcA>?	MYfEUXNQ	NYToN3dkUUN3ME2wMlgh\|ryP	NIHHc2wyQDR7NES2Ny=>
Mia Paca2	MWDDfZRwfG:6aXOgRZN{[Xl?	MnrmOVAh\|ryP	NGDaelA4Omh?	MYjEUXNQ	NWL2eG81UUN3ME2xMlEh\|ryP	MVexPFQ6PDR4Mx?=
Panc 04.03	MnWzR5l1d3SxeHnjJGF{e2G7	M{TOPVUxKM7:TR?=	NGnKPYk4Omh?	NETNT2NFVVOR	M3XFN2lEPTB;MT6yJO69VQ>?	MmHSNVg1QTR2NkO=
SU 86.86	M3qyNmN6fG:2b4jpZ{BCe3OjeR?=	MkL6OVAh\|ryP	NV\1VXVPPzKq	MXHEUXNQ	NXLRVYtMUUN3ME2xMlMh\|ryP	M3nMcVE5PDl2NE[z
HEK293	NGHMWHpMcW6jc3WgRZN{[Xl?		Mn7tN{Bp		NUHRVlE5UW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBJTEGFNjDlfJBz\XO\|aX;uJJdqfGhiSVO1NEBw\iByLkCxPUDPxE1?	NV71VYVLOTh3NUi2Olk>
HeLa	MnvkT4lv[XOnIFHzd4F6		M4qwb\|IhcA>?		MlW4TY5pcWKrdHnvckBw\iCwdXPs[YFzKEiGQVOge4l1cCCLQ{WwJI9nKDBwMEizJO69VQ>?	M4HPelE5PTV6Nk[5
RAW264.7	M{\WZWZ2dmO2aX;uJGF{e2G7	MkXxNkDPxE1?	MYSzMlUhcA>?	MWnEUXNQ	MV7BcpRqdWGuYYLpZYwh[WO2aY\peJkh[WejaX7zeEBRdGG\|bX;kbZVuKG[jbHPpdIFzfW1iaX7m[YN1\WRid3n0bEBKSzVyIH;mJFAvOTFizszN	MXmxPFY1PDl4OR?=
NB4			M2G4TlQ5cA>?	NWLCb2hFTE2VTx?=	NGrZfZdKSzVyPUCuOkDPxE1?	MmDiNVg4OjN\|NEm=
HEK293	NHLjepdHfW6ldHnvckBCe3OjeR?=	M376flExKM7:TR?=	MW[yOEBp	NILqUJdFVVOR	NEfNRWJC[3SrdnH0bY9vKG:oIH3veZNmKFewdEPhJJNq\26jbHnu[{BmgHC{ZYPz[YQ>	NX7LdY5FOTlyMkK2O\|U>
HCT116	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MU[3Nog>	NX[yZXpnTE2VTx?=	M3jy[GlEPTB;MD6zNUDPxE1?	M13oW\|E6ODh2Mkm0
HeLa	M3O5XmtqdmG\|ZTDBd5NigQ>?	M1L4OFIh\|ryP	NH21eIE{OCCvaX6=	M4f1T2ROW09?	MkTLTY5pcWKrdHnvckBw\iCKRFHDNkBqdiCqdX3hckBJ\UyjIHPlcIx{KHerdHigTWM2OCCxZjCwMlEh\|ryP	Ml65NVkxQDR{OUS=
IGROV1	M4njbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXq3NkBp	NUC2eplmTE2VTx?=	M3HSWGlEPTB;Mj6yJO69VQ>?	MW[xPVA5PDJ7NB?=
IGROV1	M3v1VGtqdmG\|ZTDBd5NigQ>?	MlX2OUDPxE1?	NUHNfJhVOjRiaB?=	MnjhSG1UVw>?	M2m5bmlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCyNUOgZYNmfHmuYYTpc44>	NY\6ZphkOTlyOESyPVQ>
IGROV1	NYjxPVk2U2mwYYPlJGF{e2G7	Mof3NVAh\|ryP	NYm4cVZ2PCCq	NF7Y[\|hFVVOR	NUHOfoNvUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHjpd5RwdmVvSESgZYNmfHmuYYTpc44>	NVXJXoJsOTlyOESyPVQ>
IGROV1	NUHsfWNxU2mwYYPlJGF{e2G7	MUSxNEDPxE1?	NF\hb481KGh?	MmG4SG1UVw>?	MVHJcohq[mm2aX;uJI9nKEiGQVO2JIF{e2W\|c3XkJIF{KGGucHjhMZR2[nWuaX6gZYNmfHmuYYTpc44>	NFTScXAyQTB6NEK5OC=>
T24	MUHLbY5ie2ViQYPzZZk>		MV:zJIg>		NV7LdlFpUW6mdXP0bY9vKG:oIHjpd5RwdmViSEOgZYNmfHmuYYTpc44hf2m2aDDFR\|UxKG:oIECuNVIh\|ryP	M1nwfFE6ODh2M{m1
T24	NH\ISWhMcW6jc3WgRZN{[Xl?		MXKzJIg>		M{D5Vmlv\HWldHnvckBw\iCjbIDoZUB1fWK3bHnuJIFk\XS7bHH0bY9vKHerdHigSWM2OCCxZjCwMlI2KM7:TR?=	MV2xPVA5PDN7NR?=
HeLa	NVnpbI8xU2mwYYPlJGF{e2G7		MXqxOUBucW5?	NXXVeIpXTE2VTx?=	Ml3wTY5pcWKrdHnvckBw\iCKRFHDOkBnem:vIH71Z4xm[XJiZYj0doFkfCC5aYToJGlEPTBib3[gNE4xQDV3IN88US=>	NIjUUpUyQTB7M{i4OC=>
HeLa	MUXLbY5ie2ViQYPzZZk>		NFHrUpgyPSCvaX6=	NX7rbHljTE2VTx?=	NF;TU3ZKdmirYnn0bY9vKG:oIFjERWM5KG[{b32gcpVkdGWjcjDlfJRz[WO2IIfpeIghUUN3MDDv[kAyNjh4IN88US=>	Mn33NVkxQTN6OES=
NCI-H69	NVHLe28yS3m2b4TvfIlkKEG\|c3H5		MVu3NkBp	MXTEUXNQ	NVvjSJRKUUN3ME2yMlA3KM7:TR?=	MVWxPVA6Ozh6NB?=
SKMES1	NIP2OXFEgXSxdH;4bYMhSXO\|YYm=		NGDsPZU4OiCq	MVTEUXNQ	M4LkRmlEPTB;Mj60NkDPxE1?	MoDNNVkxQTN6OES=
S2	NF7Od3ZMcW6jc3WgRZN{[Xl?	M3zmRlAvOS1zMDFOwG0>	MVyxJIg>		MYjJcohq[mm2aX;uJI9nKFCuYYPtc4RqfW1iZnHsZ4lx[XK3bTDISGFEOSCneIDy[ZN{\WRid3n0bEBKSzVyIH;mJFAvODV7IN88US=>	NU\IU\|RwOTl\|MUe0OVA>
SHSY5Y	M3PSOGtqdmG\|ZTDBd5NigQ>?	NF76ZnMyOCEQvF2=	NWfpeoFsPDhiaB?=	NGTsWGNFVVOR	MX;Jcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNTFOwG0>	MnLNNVk{PDRzN{W=
SHSY5Y	MYrDfZRwfG:6aXOgRZN{[Xl?	NVS0THFqOTBizszN	NH\h[FQ1QCCq	NU\4V3AxTE2VTx?=	M2HMU2lEPTB;MjFOwG0>	NF\sflQyQTN2NEG3OS=>
DMS114	NYSxSm9LT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M37FR\|Q5KGh?		NUDUXJk1T0l3ME2yMlkh\|ryP	MYqxPVQyQTJyNR?=
HBC5	MmXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEXG[IU1QCCq		MVLHTVUxRTF5IN88US=>	NW\sSY0xOTl2MUmyNFU>
SNB78	MlvmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M17PdVQ5KGh?		NUnXOFZoT0l3ME2xOkDPxE1?	MXmxPVQyQTJyNR?=
HeLa	M1fSd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NWP0XHhxPzJiaB?=	M3fxSWROW09?	Mm[2TWM2OD1yLkS2JO69VQ>?	NX\L[YM4OTl2NEG4OFY>
BHK	M4DJO2tqdmG\|ZTDBd5NigQ>?	MkTzOUDPxE1?	NVjLOXhpOjRiaB?=	M{XVSmROW09?	MoDVTY5pcWKrdHnvckBw\iCKRFHDO{BmgHC{ZYPz[YQh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gdIxie22jIH3lcYJz[W6nIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4>	MYKxPVk3Pjd6OR?=
CFBE41o-	NEHtS5lMcW6jc3WgRZN{[Xl?	NVm3eHZCPSEQvF2=	MVy4JIg>	MUjEUXNQ	NH3vfZJKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaInw[ZJi[2W2eXzheIlwdiCxZjDobZN1d26nIFiz	M1nCclE6QTZ4N{i5
CFBE41o-	NV;qdYhKU2mwYYPlJGF{e2G7	Mke2OUDPxE1?	Ml61OEBp	MYfEUXNQ	NWTxPWxLUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJI12fGGwdDDG[IVtfGF3MEigR2ZVWiCycn;0[YlvKGyndnXs	NIHPVJoyQTl4Nke4PS=>
CFBE41o-	MWTLbY5ie2ViQYPzZZk>	MoTUNUDPxE1?	MVixJIg>	NXewPWRiTE2VTx?=	MWDJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iQ1\UVkBxem:2ZXnuJIxmfmWu	NFn4R5gyQTl4Nke4PS=>
Primary bronchial epithelial cell	MnnMT4lv[XOnIFHzd4F6	NUT3V\|dWOSEQvF2=	NVjYUIpiOjRiaB?=	M2DLbmROW09?	NX\IXogyUW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhdXW2YX70JGZl\Wy2YUWwPEBETlSUIIDyc5RmcW5iYYDpZ4FtKHO3cn\hZ4UhdG:lYXzpfoF1cW:w	NUfLTlhXOTl7Nk[3PFk>
CFBE41o-	MorlT4lv[XOnIFHzd4F6	MVqxJO69VQ>?	MXu1JIRigXN?	M3jHbmROW09?	NYnPTVVQUW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckB{fGGkaXzpfoF1cW:wIH;mJGZl\Wy2YUWwPEBETlSUIIDyc5RmcW5?	M4jBNVE6QTZ4N{i5
CFBE41o-	M3HnOmtqdmG\|ZTDBd5NigQ>?	MWqxJO69VQ>?	M3rEdFI1KGh?	NF[4dnNFVVOR	NU\iVlJ{UW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBH\GWudHG1NFghS0[WUjDwdo91\WmwIITyZYZncWOtaX7n	MnfGNVk6PjZ5OEm=
CFBE41o-	M4jjfGtqdmG\|ZTDBd5NigQ>?	Mnq2OUDPxE1?	M{TNfVI1KGh?	M4XZd2ROW09?	NWPHUoc6UW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBz[XSnIH;mJI1ifHW{YYTpc44hd2ZiQ1\UVkBxem:2ZXnuJJRwKGm2czDncJlkd2[xcn2=	MWSxPVk3Pjd6OR?=
CFBE41o-	MUHLbY5ie2ViQYPzZZk>	NUX2U2d7PSEQvF2=	NY\wNnJZOjRiaB?=	NWXFUlA3TE2VTx?=	MXHJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIIP0ZYJqdGm2eTDv[kBH\GWudHG1NFghS0[WUjDwdo91\Wmw	NUDNS4hDOTl7Nk[3PFk>
CFBE41o-	NGH4NGVMcW6jc3WgRZN{[Xl?	MoK0OUDPxE1?	NE\JUIYzPCCq	NWXMOI9pTE2VTx?=	MUTJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W\|c3XkJIF{KGOxcoLlZ5Rqd25ib3[gcZV1[W62IF\k[Yx1[TVyODDDSnRTKHS{YX\mbYNscW6pIITvJINmdGxic4Xy[oFk\SCjczDncJlkd2[xcn2=	M3nxZlE6QTZ4N{i5
Primary bronchial epithelial cell	M3zZXmtqdmG\|ZTDBd5NigQ>?	Mkj4OUDPxE1?	MmO2NlQhcA>?	NEHFW2ZFVVOR	Ml7STY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwZIXjeIlwdiCxZjDteZRidnRiRnTlcJRiPTB6IFPGWHIheHKxdHXpckBieGmlYXygd5Vz\mGlZTDsc4NidGm8YYTpc44>	M2KyT\|E6QTZ4N{i5
Primary bronchial epithelial cell	NED6Z21McW6jc3WgRZN{[Xl?	M1TuWVEh\|ryP	M4DFOVk3KGh?	MVTEUXNQ	NH;TSJlKdmirYnn0bY9vKG:oIFjERWM4KGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJJNpd3K2IHPpdoN2cXRiY4XydoVvfHN?	NYDsR41nOTl7Nk[3PFk>
BxPC3	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXe3NkBp		NX7hcpRCUUN3ME2yMlch\|ryP	M1jwSlIxOTR\|N{e4
CAL27	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MmfFO\|IhcA>?		M2DQN2lEPTB;Mz63NkDPxE1?	MoX4NlAyPDN5N{i=
Capan1	MmmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MofqO\|IhcA>?		M{TvT2lEPTB;Nz6zJO69VQ>?	NVrxUYtuOjBzNEO3O\|g>
HCC827	NXH1SXE{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NXG1eHpkPzJiaB?=		NVvVPHhWUUN3ME2xMlgh\|ryP	NITNZoUzODF2M{e3PC=>
LNCAP	M{jDVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWW3NkBp		MVPJR\|UxRTBwNUig{txO	Mlq5NlAyPDN5N{i=
NCI-H2122	M3vkdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NEewNGg4OiCq		NIPIfnVKSzVyPUeuOUDPxE1?	MmrjNlAyPDN5N{i=
NCI-H358	M2LVfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NUXocphvPzJiaB?=		M4fJeWlEPTB;Mj61JO69VQ>?	MV6yNFE1Ozd5OB?=
SCC15	MnrQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWfyTnc1PzJiaB?=		NVTxe3I5UUN3ME2yMlQ6KM7:TR?=	MkTaNlAyPDN5N{i=
SCC25	M3;mdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmHjO\|IhcA>?		NYXLbIdvUUN3ME2xMlk{KM7:TR?=	NWHVe\|UxOjBzNEO3O\|g>
SKHEP1	M{Hj[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M3r3V\|czKGh?		Mm\ZTWM2OD1\|LkS2JO69VQ>?	MVyyNFE1Ozd5OB?=
BJ	MnThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NFX1Z\|IyODBizszN	M1WyWFQ5KGh?	M3;jcWROW09?	MXrHdo94fGhiaX7obYJqfGmxbjDheEAxNjB3IITvJFExOCC3TR?=	M1XQTVIxOTR\|OESw
MUF	MoL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MoTVNVAxKM7:TR?=	NFfTU2E1QCCq	M2\HT2ROW09?	NVHXOmV[T3Kxd4ToJIlvcGmkaYTpc44h[XRiMD6wOUB1dyBzMECgeW0>	NVzUOJlbOjBzNEO4OFA>
Caco-2	M1OxcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1LM[\|ExOCEQvF2=	MYe0PIg>	M33ve2ROW09?	NF3DN2dKSzVyPUiuNUDPxE1?	MmnJNlAyPDN6NEC=
Caco-2	Mn20T4lv[XOnIFHzd4F6	MkTPOUDPxE1?	NFL3dJA1KGh?	Mk\SSG1UVw>?	NF7FTopKdmS3Y4Tpc44hd2ZiSFTBR{1u\WSrYYTl[EBpcXO2b37lJIFk\XS7bHH0bY9vKEmFNUCgc4YhOC5yM{eg{txO	MWSyNFE1Ozh2MB?=
Caco-2	MWTLbY5ie2ViQYPzZZk>	NXTDbJNpOC5\|MU[gcm0hfG9iM{GuOkDPxE1?	MoH0OEBp	M3LnWWROW09?	MWjFfEB3cX[xIHnubIljcXSrb36gc4YhcHWvYX6gTGRCSzFid3n0bEBKSzVyIH;mJFAvOTF7IN88US=>	NHTESHEzODF2M{i0NC=>
Caco-2	MWnLbY5ie2ViQYPzZZk>	M1LiO\|AvOzF4IH7NJJRwKDNzLk[g{txO	NYH2[JdqPCCq	MnmxSG1UVw>?	MmG2SZghfmm4bzDpcohq[mm2aX;uJI9nKGi3bXHuJGhFSUN\|IIfpeIghUUN3MDDv[kAxNjF2NzFOwG0>	MoWxNlAyPDN6NEC=
Caco-2	MVnLbY5ie2ViQYPzZZk>	NFPhZWg3NjN{IH7NJJRwKDZ\|MjFOwG0>	NXrMVYFnPCCq	NXfLSZI1TE2VTx?=	MkKwSZghfmm4bzDpcohq[mm2aX;uJI9nKGi3bXHuJGhFSUN3IIfpeIghUUN3MDDv[kAyOi54IN88US=>	NVrNW3lQOjBzNEO4OFA>
Caco-2	M3Sw[2tqdmG\|ZTDBd5NigQ>?	NI[zeWI3NjN{IH7NJJRwKDZ\|MjFOwG0>	NFnmVHY1KGh?	NYj1SZpOTE2VTx?=	NHPGTppGgCC4aY\vJIlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{ege4l1cCCLQ{WwJI9nKDRzIN88US=>	MlHFNlAyPDN6NEC=
Caco-2	MWrLbY5ie2ViQYPzZZk>	NYC5e2o3OC5\|MU[gcm0hfG9iM{GuOkDPxE1?	MVq0JIg>	NXq0VFduTE2VTx?=	M3PkXmV5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFNh?=	MYWyNFE1Ozh2MB?=
HepG2	MU\LbY5ie2ViQYPzZZk>	M4X6OVUh\|ryP	MYq2bC=>	NGn1U3dFVVOR	NFzBbVRKdmS3Y4Tpc44hd2ZiSFTBR{1u\WSrYYTl[EBpcXO2b37lJIFk\XS7bHH0bY9v	M{[2XlIxOTR\|OESw
HepG2	MWnLbY5ie2ViQYPzZZk>	MWG1JO69VQ>?	M1PWWlZp	Mm\xSG1UVw>?	MmPSTY5lfWO2aX;uJI9nKEiGQVOtcYVlcWG2ZXSgbIl{fG:wZTDofZBmemGlZYT5cIF1cW:w	M3XwTVIxOTR\|OESw
HepG2	NIni[XdMcW6jc3WgRZN{[Xl?	MUe1JO69VQ>?	MUm2bC=>	MXHEUXNQ	M4PsT2lv\HWldHnvckBw\iCKRFHDMY1m\GmjdHXkJIFteGijLYT1ZpVtcW5iYXPleJlt[XSrb36=	MVqyNFE1Ozh2MB?=
HepG2	NV\wRYd2U2mwYYPlJGF{e2G7	MWG1JO69VQ>?	MmKwOog>	MmfKSG1UVw>?	NUTlOWRNUW6mdXP0bY9vKG:oIFjERWMudWWmaXH0[YQhUDNxSESgbIl{fG:wZTDhZ4V1gWyjdHnvci=>	MYmyNFE1Ozh2MB?=
COLO205	M3\URmtqdmG\|ZTDBd5NigQ>?	M2XqW\|ExKM7:TR?=	NX\JR2g4OjRiaB?=	M1HsVmROW09?	NFS2fm1KdmirYnn0bY9vKG:oIFjERWMyKGG\|c3Xzd4VlKGG\|IHnu[JVkfGmxbjDv[kBpcXO2b37lJGg{KGGlZYT5cIF1cW:wIIfpeIghUUN3MDDv[kAzNjJizszN	NEXwTWQzODR3MUO3PC=>
SCC4	NYjadlBvU2mwYYPlJGF{e2G7	MYWxJO69VQ>?	MlXmNlRp		MonFTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIIT1ZpVtcW5iYXPleJlt[XSrb36=	NXrwb5J1OjB2NUKyNlU>
SCC4	M4\2d2tqdmG\|ZTDBd5NigQ>?	MUSxJO69VQ>?	NGXxOHAzPGh?		MUfJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCjY3X0fYxifGmxbh?=	Mn33NlA1PTJ{MkW=
SCC4	MXXGeY5kfGmxbjDBd5NigQ>?	NFnM[m4yKM7:TR?=	NEDlPHc2KG2rbh?=		NH;vbYNC\2:waYP0JIFkfGm4aYT5JIF1KF[GUjDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZiQ2nQNlQh\2WwZTDlfJBz\XO\|aX;u	Mnj2NlA1PTJ{MkW=
NB4	MlP2SpVv[3Srb36gRZN{[Xl?	NVTlRWV6PSEQvF2=	Mmm1NlQhcA>?	Mo\4SG1UVw>?	MV\D[YxtKGO7Y3zlJIFzemW\|dDDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCjY3P1cZVt[XSrb36gZZQheHKnLVexJJBp[XOn	NHqyTY8zODR7MUS0NC=>
NB4	M4H2R2tqdmG\|ZTDBd5NigQ>?	NEDwUnY2KM7:TR?=	NYP1To5VOjRiaB?=	M4ThWWROW09?	M4DFfGlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDhZ4V1gWyjdHWgeJVjfWyrbjDs[ZZmdA>?	MWKyNFQ6OTR2MB?=
NB4	NH3SZYJHfW6ldHnvckBCe3OjeR?=	Mnq1OUDPxE1?	MViyOEBp	NVTxcoo4TE2VTx?=	MYfJcoR2[3Srb36gc4YheDJzV1HGNU9EUVBzIHX4dJJme3Orb36=	NGTCO4kzODR7MUS0NC=>
NB4	M3nLOWtqdmG\|ZTDBd5NigQ>?	NGTheHk2KM7:TR?=	MlLBNlQhcA>?	Ml3ISG1UVw>?	NFq0XGNKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{Bi[2W2eXzheIlwdg>?	MnfSNlA1QTF2NEC=
NUGC3	MmDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml34S2k2OD1{Lkm0JO69VQ>?	M3zsS\|IxQDVyOUex
A549	Mn7NSpVv[3Srb36gRZN{[Xl?	MkTjOUDPxE1?	MYezJIg>	NYPVWnpsTE2VTx?=	M2fkN2lv\HWldHnvckBw\iCjdYTvdIhi\3liaX6gbJVu[W5iQUW0PUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCOQ{PJTS=>	MVWyNFg2PTJyOB?=
HUT78	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MV:3NkBp	M{Pnd2ROW09?	NVXCd2NWT0l3ME2wMlMh\|ryP	MWmyNFg5PDJyOB?=
U937	M2fze2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M37XO\|czKGh?	MUDEUXNQ	MVjHTVUxRTBwM{mg{txO	MkmxNlA5QDR{MEi=
A431	NYPnUFE5S3m2b4TvfIlkKEG\|c3H5		M{DxT\|czKGh?		NVHES\|F5S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTR\|MTDj[YxteyCxdnXy[ZhxemW\|c3nu[{BGT0[UIIfpeIghUUN3MDDv[kA1NjJizszN	M{nXU\|IyODhyNkK5
A549	MVTDfZRwfG:6aXOgRZN{[Xl?		M3zrUVczKGh?		NGHOSnJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KG:4ZYLlfJBz\XO\|aX7nJGhFSUNid3n0bEBKSzVyIH;mJFEvQCEQvF2=	M3PKTFIyODhyNkK5
CAL27	MnzJR5l1d3SxeHnjJGF{e2G7		NV7Rc2J4PzJiaB?=		NX\NVmRTS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hS0GOMkegZ4VtdHNib4\ldoV5eHKnc4PpcochTUeIUjD3bZRpKEmFNUCgc4YhOy5{IN88US=>	Mm\tNlExQDB4Mkm=
HeLa	NHm4O3pEgXSxdH;4bYMhSXO\|YYm=		MlrWO\|IhcA>?		NGXhWJJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KG:4ZYLlfJBz\XO\|aX7nJGhFSUNid3n0bEBKSzVyIH;mJFEvPSEQvF2=	M1\zTFIyODhyNkK5
Sf21	MYTLbY5ie2ViQYPzZZk>		MnvwN{Bp		NFzjXmtKdmirYnn0bY9vKG:oIF\sZYchfGGpZ3XkJIh2dWGwIILlZ49u[mmwYX70JGhFSUN6IHX4dJJme3OnZDD3bZRpKEmFNUCgc4YhOS5{IN88US=>	M1;YTlIyODhyNkK5
SKBR3	NH71bFFEgXSxdH;4bYMhSXO\|YYm=		MVS3NkBp		MXLDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT2JTOyClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCyMlYh\|ryP	MWiyNVA5ODZ{OR?=
SKOV3	NGrJS5lEgXSxdH;4bYMhSXO\|YYm=		NEDtUFk4OiCq		MX;DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT29XOyClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCyMlIh\|ryP	MWqyNVA5ODZ{OR?=
COR-L23	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml\VNVAh\|ryP	M{jqUlczKGh?	MWXEUXNQ	NV\hfVlKT0l3ME2xMlEh\|ryP	MmTzNlExQDB4NEe=
DU145	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NFTzVXAyOCEQvF2=	Ml\XO\|IhcA>?	Mmr5SG1UVw>?	M1L4c2dKPTB;MT6wOUDPxE1?	NYH2fpl1OjFyOEC2OFc>
LoVo	NWDqUWdzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M1nIfFExKM7:TR?=	NYj4blNuPzJiaB?=	NHL0bZpFVVOR	M{\1bGdKPTB;MT63JO69VQ>?	M3HXdVIyODhyNkS3
MCR5-SV2	M1vzVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVWxNEDPxE1?	NVnCV5pqPzJiaB?=	Ml7WSG1UVw>?	Ml7mS2k2OD1{LkGg{txO	MkHMNlExQDB4NEe=
HCT116	MoS2T4lv[XOnIFHzd4F6	NUfxd202OzBizszN	Mlj2N\|AhcA>?	M1TlXWROW09?	MUPJcohq[mm2aX;uJI9nKEiGQVO2JIF{e2W\|c3XkJIF{KGmwZIXjeIlwdiCxZjDhcJBp[S22dXL1cIlvKGGlZYT5cIF1cW:w	NHz0RmUzOTB6ME[0Oy=>
HCT116	NEXtfJNMcW6jc3WgRZN{[Xl?	NF\kfoU{OCEQvF2=	NWHKRXNjOzBiaB?=	NFrXVIdFVVOR	M1Lu[2lvcGmkaYTpc44hd2ZiSFTBR\|Eh[XO\|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJIhqe3SxbnWgTFNMQSCjY3X0fYxifGmxbh?=	MmT2NlExQDB4NEe=
U937	MV3LbY5ie2ViQYPzZZk>	M3:0VlUh\|ryP	MkK4NlQhcA>?	M2j5RmROW09?	NHvZ[2FKdmirYnn0bY9vKG:oIHjpd5RwdmViYXPleJltfHKjboPm[ZJie2ViYYPz[ZN{\WRiYYOgbY5kemWjc3Wgc4Yh[WOndInsZZRqd25ib3[gbIl{fG:wZTDIN{BifCCNOR?=	NW\hRVd3OjF{OUK0PVI>
U937	Ml\CT4lv[XOnIFHzd4F6	MX21JO69VQ>?	M2HUZlI1KGh?	M3\QeWROW09?	NEDv[3JKdmirYnn0bY9vKG:oIHjpd5RwdmViYXPleJltfHKjboPm[ZJie2ViYYPz[ZN{\WRiYYOgbY5kemWjc3Wgc4Yh[WOndInsZZRqd25ib3[gbIl{fG:wZTDIN{BifCCNMUi=	MkjaNlEzQTJ2OUK=
U937	NX\WTGZHU2mwYYPlJGF{e2G7	M4jiOVUh\|ryP	NH;4eZIzPCCq	NV31TopyTE2VTx?=	NILseYFKdmirYnn0bY9vKG:oIHjpd5RwdmViYXPleJltfHKjboPm[ZJie2ViYYPz[ZN{\WRiYYOgbY5kemWjc3Wgc4YheGGwLXHj[ZR6dGG2ZXSgbIl{fG:wZTDIOEBt\X[nbB?=	MnjXNlEzQTJ2OUK=
U937	NInadZdMcW6jc3WgRZN{[Xl?	MoD6OUDPxE1?	MnzWNVUhdWmw	NIm2fGdFVVOR	M2jY[mlvcGmkaYTpc44hd2ZiaHnzeI9v\SCjY3X0fYx1emGwc3\ldoF{\SCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDv[kBpcXO2b37lJGg{KGGlZYT5cIF1cW:wIHzleoVt	M33LdlIyOjl{NEmy
A2780	NYfXO4pYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		Mof4PVYhcA>?	M4nPXWROW09?	MoHoTWM2OD1zLk[yJO69VQ>?	MkH0NlE3OzR2M{C=
COLO205	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXq5OkBp	MX3EUXNQ	MXvJR\|UxRTJwMUKg{txO	M4LhVVIyPjN2NEOw
Hep3B	M2[3R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NHf3WlA1QCCq	NEXS[G1FVVOR	MYXHTVUxRTFwMkGg{txO	MkjDNlE4OTJzNE[=
GM11272	NX3YWXM4TnWwY4Tpc44hSXO\|YYm=	MYqxNFAhdk1?	Mn\6O\|IhcA>?	M3f4cGROW09?	MXvS[YFkfGm4YYTpc44hd2ZiTXXDdFIhdXW2YX70JIV5eHKnc4Ppc44h[XRiMUCgeI8hOTByIH7N	M1i3TlIyQDRyN{G2
CFBE41o	NHy0epZMcW6jc3WgRZN{[Xl?	NXf4[lBRPSEQvF2=		NV3pOldSTE2VTx?=	M4SzdWRwf25icnXneYxifGmxbjDv[kBJTEGFNzDheEAxNjJidH:gOUB2VQ>?	NYXZPVR7OjF7OES5OVg>
CFBE41o	NYDuSFI3TnWwY4Tpc44hSXO\|YYm=	MUCxJO69VQ>?	MUWyOEBp	NH;OUpRFVVOR	MYHS[ZN1d3KjdHnvckBw\iCFRmTSJIRmdHSjRkWwPEBufXSjboSgeJJi\m[rY3vpcochfG9iY3XscEB{fXKoYXPlJIF{KGeueXPv[o9zdXN?	NUexe3lmOjF7OES5OVg>
DU145	MlrFT4lv[XOnIFHzd4F6	M2TMflIvPSEQvF2=	MYeyOEBp	NFzmVGFFVVOR	M1;HTWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyC3cILl[5Vt[XSrb36gc4YheDJzd3HmNUBxem:2ZXnuJIV5eHKnc4Ppc44>	MYqyNlI3ODF4Nh?=
DU145	NXnqW2E2U2mwYYPlJGF{e2G7	NG\XW5c2KM7:TR?=	MXuyOEBp	MYTEUXNQ	M3XPe2lvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCqaYP0c45mKEh2IHHj[ZR6dGG2aX;u	NFvwVIYzOjJ4MEG2Oi=>
DU145	M4r5RWtqdmG\|ZTDBd5NigQ>?	NWHDVWpWPSEQvF2=	M1S2Z\|I1KGh?	M2TLdmROW09?	NWi0TZpPUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHjpd5RwdmViSEOgbJlx\XKjY3X0fYxifGmxbh?=	NGXtfo4zOjJ4MEG2Oi=>
786-0	NIT4[ZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHX0OYQ3NjJizszN	MkLRO\|IhcA>?	MoPqSG1UVw>?	NVnndYhDT0l3ME2zMlIh\|ryP	MWGyNlQ{PTZ4OR?=
A498	NHzLdIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVf1fndVPi5{IN88US=>	M{e2N\|czKGh?	NIjYd2FFVVOR	MYPHTVUxRTFwNjFOwG0>	MlzONlI1OzV4Nkm=
A549/ATCC	NWnhXphWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIfwcoE3NjJizszN	NV7EVXM3PzJiaB?=	M4jyZmROW09?	MXvHTVUxRTFwNjFOwG0>	MVKyNlQ{PTZ4OR?=
ACHN	M{fmW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2[4[\|YvOiEQvF2=	MYq3NkBp	M4PMUWROW09?	NIG5VZZIUTVyPUGuN{DPxE1?	NIrUc5kzOjR\|NU[2PS=>
BT549	MlizS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M17kU\|YvOiEQvF2=	MlPhO\|IhcA>?	Mke4SG1UVw>?	NYfNSY57T0l3ME2xMlMh\|ryP	NFjodWczOjR\|NU[2PS=>
EKVX	M{XmSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Ml32Ok4zKM7:TR?=	M2TPTVczKGh?	NGm5V2pFVVOR	NUnKWWpPT0l3ME2xMlMh\|ryP	NIO3N4MzOjR\|NU[2PS=>
HCT15	Ml:4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NVTlfHpEPi5{IN88US=>	MYW3NkBp	NV3Eeo5iTE2VTx?=	MUXHTVUxRTJwNTFOwG0>	NHruUW4zOjR\|NU[2PS=>
HOP92	NW\Fb2d{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MXK2MlIh\|ryP	Mn\6O\|IhcA>?	NXvkUYhxTE2VTx?=	MXLHTVUxRTRizszN	NEfyfWczOjR\|NU[2PS=>
IGROV1	M1;DVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NIH3S4s3NjJizszN	NE[2c5A4OiCq	NHroeVdFVVOR	NUfyZpFGT0l3ME2xMlMh\|ryP	MWSyNlQ{PTZ4OR?=
LOXIMVI	NFjvWXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVi2MlIh\|ryP	MmLpO\|IhcA>?	MknQSG1UVw>?	M4O3VGdKPTB;MTFOwG0>	MVSyNlQ{PTZ4OR?=
M14	NYPiXnJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIizWHc3NjJizszN	NVjQR2JrPzJiaB?=	MXTEUXNQ	MXPHTVUxRTFwMzFOwG0>	MlTYNlI1OzV4Nkm=
MALME-3M	NELCcoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEfDb2U3NjJizszN	NH;wR2Y4OiCq	NGrSW\|ZFVVOR	MXrHTVUxRTBwM{Kg{txO	MmLSNlI1OzV4Nkm=
MCF10A	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXq2MlIh\|ryP	MUK0PEBp	M2ryW2ROW09?	M2DXOmdKPTB;OT62JO69VQ>?	MX:yNlQ{PTZ4OR?=
MDA-MB-435	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MX22MlIh\|ryP	MUi3NkBp	MUnEUXNQ	NVHp[lB2T0l3ME2wMlUh\|ryP	MnW1NlI1OzV4Nkm=
MDA-MB-468	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3\WTVYvOiEQvF2=	NGfFS\|U4OiCq	MlfoSG1UVw>?	M2TDNGdKPTB;MD62N{DPxE1?	MnXFNlI1OzV4Nkm=
MOLT4	NGDtcVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NFLnOFk3NjJizszN	NX\XZmR4PzJiaB?=	NH;qempFVVOR	Ml3YS2k2OD1yLkSg{txO	Mo\oNlI1OzV4Nkm=
NCI-ADR-RES	Mm\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NGP4Omg3NjJizszN	NH\mUXA4OiCq	Ml3ESG1UVw>?	NWLSdnN3T0l3ME2wMlE3KM7:TR?=	MmHwNlI1OzV4Nkm=
NCI-H23	NVTnTGJMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MVK2MlIh\|ryP	NFHZbFM4OiCq	MkLoSG1UVw>?	MoTuS2k2OD1zIN88US=>	MVKyNlQ{PTZ4OR?=
NCI-H322M	NIfENGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NVjFRXprPi5{IN88US=>	NIKxRZY4OiCq	MlPkSG1UVw>?	NVTENoZ1T0l3ME2wMlc6KM7:TR?=	NFrTfVUzOjR\|NU[2PS=>
NCI-H460	M{nIb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NUjrSJpVPi5{IN88US=>	MknaO\|IhcA>?	NUH6R455TE2VTx?=	M1zYZmdKPTB;MD63PUDPxE1?	NXXU[\|JvOjJ2M{W2Olk>
NCI-H522	NH:5dZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYHaWmhOPi5{IN88US=>	MlPoO\|IhcA>?	M4HJXmROW09?	NVjxfYpwT0l3ME2wMlUh\|ryP	M1nKZVIzPDN3Nk[5
OVCAR3	NHTrOXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHXQN3I3NjJizszN	MXG3NkBp	NVriU2J4TE2VTx?=	MWTHTVUxRTFwMzFOwG0>	NF\mfG0zOjR\|NU[2PS=>
OVCAR4	MoHFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NHj0bFI3NjJizszN	NYfKPIZPPzJiaB?=	MXHEUXNQ	M2DnXmdKPTB;NDFOwG0>	NULGRVVIOjJ2M{W2Olk>
OVCAR5	NFjSO2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MVu2MlIh\|ryP	M2frdVczKGh?	MmXFSG1UVw>?	M3qyWWdKPTB;MD63PUDPxE1?	MYiyNlQ{PTZ4OR?=
OVCAR8	NVzUR5BvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVnoSI1TPi5{IN88US=>	MYS3NkBp	M3XObWROW09?	M3vSW2dKPTB;MD61JO69VQ>?	NYr3[GQ3OjJ2M{W2Olk>
RXF393	NHfTUFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NIDIVmI3NjJizszN	MYO3NkBp	MUHEUXNQ	NY\pblJ3T0l3ME2xMlMh\|ryP	NWjSW4M6OjJ2M{W2Olk>
SF268	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHi3dYY3NjJizszN	M2q3elczKGh?	Ml[4SG1UVw>?	MnPZS2k2OD1zLk[g{txO	NYm2eYVkOjJ2M{W2Olk>
SF295	NEK2e\|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MnrjOk4zKM7:TR?=	NIjJRmk4OiCq	MmDUSG1UVw>?	MmnzS2k2OD1zLk[g{txO	MUiyNlQ{PTZ4OR?=
SF539	MkH6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M{fLc\|YvOiEQvF2=	M{S1W\|czKGh?	NF;nU45FVVOR	MULHTVUxRTJizszN	NHm3TWIzOjR\|NU[2PS=>
SK-MEL-2	M2CyTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NFTEOYk3NjJizszN	MnfJO\|IhcA>?	NWXibG9YTE2VTx?=	Ml6xS2k2OD1zLkOg{txO	NXjHT3BROjJ2M{W2Olk>
SK-MEL-28	NV:0V2p[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUi2MlIh\|ryP	MoLUO\|IhcA>?	MVrEUXNQ	NXe3T4lXT0l3ME2xJO69VQ>?	M364WFIzPDN3Nk[5
SK-MEL-5	NU[3V\|M1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGTD[Vk3NjJizszN	MXO3NkBp	NG\WWFlFVVOR	M1;1N2dKPTB;MD62N{DPxE1?	M3juWVIzPDN3Nk[5
SKOV3	M1GxRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlvyOk4zKM7:TR?=	MYG3NkBp	MmLrSG1UVw>?	NWXzWJNkT0l3ME2xJO69VQ>?	MYGyNlQ{PTZ4OR?=
SN12C	NEnNN\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWrmU3RRPi5{IN88US=>	M3vNSlczKGh?	MoLDSG1UVw>?	NUj6XodIT0l3ME2yJO69VQ>?	NYTzVo8zOjJ2M{W2Olk>
SNB19	M2\mOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlnvOk4zKM7:TR?=	M1vOc\|czKGh?	MX7EUXNQ	MXHHTVUxRTBwNkOg{txO	MWGyNlQ{PTZ4OR?=
SNB75	NILpcFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MoSwOk4zKM7:TR?=	M2rkVVczKGh?	NX\PSIVjTE2VTx?=	MoSyS2k2OD1yLke5JO69VQ>?	M4n2UVIzPDN3Nk[5
SR	MlX5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3XoNFYvOiEQvF2=	MV63NkBp	MVPEUXNQ	M3rtO2dKPTB;MD60JO69VQ>?	NFv1T2UzOjR\|NU[2PS=>
T47D	MnnXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M1Pj[VYvOiEQvF2=	NVjm[mZUPzJiaB?=	MnzISG1UVw>?	NYTvc5JFT0l3ME2wMlUh\|ryP	MWWyNlQ{PTZ4OR?=
TK10	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M4DoOFYvOiEQvF2=	MoDYO\|IhcA>?	M3XJVGROW09?	MmnZS2k2OD1yLk[zJO69VQ>?	NHzGTnMzOjR\|NU[2PS=>
UACC257	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NUXEWYFKPi5{IN88US=>	MoSzO\|IhcA>?	NXzCbYttTE2VTx?=	M4nxNWdKPTB;MD61JO69VQ>?	M1n2U\|IzPDN3Nk[5
UACC62	Mk[zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVW2MlIh\|ryP	MlHGO\|IhcA>?	NIrqVppFVVOR	MU\HTVUxRTBwNDFOwG0>	NH7IN2EzOjR\|NU[2PS=>
UO31	NGjXOolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MkfQOk4zKM7:TR?=	M4rUeVczKGh?	MnPSSG1UVw>?	MU\HTVUxRTBwNTFOwG0>	NVTHeYl4OjJ2M{W2Olk>
Hep3B	M{K4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MlrFOFghcA>?	Mle0SG1UVw>?	M2juN2dKPTB;MD62PUDPxE1?	M1n4SVIzPDN7OE[z
BE(2)-C	NWTvWpp7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHjUU5g4OiCq	MVfEUXNQ	MnrZTWM4OD1{IN88US=>	MXmyNlk{OjNzNh?=
Bel7402	NIPifotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MoW0O\|IhcA>?	NIi0dnFFVVOR	NHvzT\|NIUTlyPUG3JO69VQ>?	NGfKTnUzOzB4MUO3Oi=>
Bel7404	NGGyUVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{\0dVczKGh?	M1;xeWROW09?	NHT6[nRIUTlyPUG4JO69VQ>?	MUCyN\|A3OTN5Nh?=
BGC823	NF\DbHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXy3NkBp	MVnEUXNQ	M{jHdmdKQTB;Nz61JO69VQ>?	NGX4eZYzOzB4MUO3Oi=>
MGC803	NHPuTm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		Mn;RO\|IhcA>?	MnHFSG1UVw>?	MXHHTVkxRTFyLkig{txO	NVn6XnVbOjNyNkGzO\|Y>
SGC7901	NVS3UnZ2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIrXd3E4OiCq	MXvEUXNQ	NYiwdXZRT0l7ME25MlQh\|ryP	M2TQNFI{ODZzM{e2
SKHEP1	MmnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M320R\|czKGh?	M2PEemROW09?	MYDHTVkxRTF5IN88US=>	MofFNlMxPjF\|N{[=
SMMC7721	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MXK3NkBp	NY\LS\|BPTE2VTx?=	MkLKS2k6OD1{MDFOwG0>	MnnONlMxPjF\|N{[=
NUGC3	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NGLIe5kyOCEQvF2=			MVjHTV0zNjl2IN88US=>	MormNlMyPjN\|M{K=
A2780 CisR	Mn\2T4lv[XOnIFHzd4F6		MVWxPEBp		MXnJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNESg{txO	MW[yN\|I2OjZyMx?=
CAL27 sens	MknVT4lv[XOnIFHzd4F6		NV\xbFlLOThiaB?=		NGLH[FdKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR\|UxKG:oIECuN\|Yh\|ryP	M3vPTlI{OjV{NkCz
CAL27 CisR	MUHLbY5ie2ViQYPzZZk>		M1jJbFE5KGh?		MXnJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNkGg{txO	MWiyN\|I2OjZyMx?=
KYSE-510 CisR	M4PZOGtqdmG\|ZTDBd5NigQ>?		MYKxPEBp		MYjJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNUmg{txO	NGPIbZozOzJ3Mk[wNy=>
KYSE-510 sens	NXr3Z2puU2mwYYPlJGF{e2G7		NVnQdGNQOThiaB?=		MUHJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNzFOwG0>	Mn:zNlMzPTJ4MEO=
MDA-MB-231 sens	MlvoT4lv[XOnIFHzd4F6		NYn2O2x2OThiaB?=		NYnsfJJIUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlYyKM7:TR?=	NGruUIQzOzJ3Mk[wNy=>
MDA-MB-231 CisR	MmXCT4lv[XOnIFHzd4F6		MYCxPEBp		M{joO2lvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD62NUDPxE1?	MkLINlMzPTJ4MEO=
ES2	MnzpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MXu0PEBp	MVzEUXNQ	M{PtOGlEPTB;MUKuO{DPxE1?	NYfMemZ4OjN2OUO0OFk>
MDA-MB-231	NWfabo9qU2mwYYPlJGF{e2G7	NIDYT\|QyOCEQvF2=	Mn;iN\|AhdWmw	M4f0d2ROW09?	NUnmW4NHUW6qaXLpeIlwdiCxZjDISGFEOmF?	MmTrNlM1QTN2NEm=
MDA-MB-231	NXrKOWV4U2mwYYPlJGF{e2G7	MlrBNUDPxE1?	MVSyOEBp	MXrEUXNQ	M4XYWWlvcGmkaYTpc44hd2ZiSFTBR\|Yh[XO\|ZYPz[YQh[XNiYXPleJlt[XSrb36gcIV3\Wy\|IH;mJJR2[nWuaX6=	M1rheVI{PDl\|NES5
HS68	NGHwZ5lEgXSxdH;4bYMhSXO\|YYm=	NGn1OpIyOCEQvF2=	MW[3NkBp	NYn4NmpkTE2VTx?=	Mny3TWM2OD12Lk[g{txO	M3XYZVI{PTdyNUSy
MEF	MUjDfZRwfG:6aXOgRZN{[Xl?	M4TVU\|ExKM7:TR?=	NV60Z2lYPzJiaB?=	M4X3W2ROW09?	NWLPT413UUN3ME20MlQh\|ryP	Ml7aNlM2PzB3NEK=
BGC823	Ml2wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NWH6S2NOTE2VTx?=	M3LV[WdKPTB;Mz6wPUDPxE1?	MmLZNlM3ODF5ME[=
High5	MY\LbY5ie2ViQYPzZZk>		NVjLSXJWOjRiaB?=		NFvhdItKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWM3KHerdHigTWM2OCCxZjCwMlA6KM7:TR?=	Mn3DNlM3ODJ3MkO=
High5	M4O0TWtqdmG\|ZTDBd5NigQ>?		MonFNlQhcA>?		M1;pc2lvcGmkaYTpc44hd2ZiaIXtZY4hemWlb33ibY5idnRiSFTBR\|Ehf2m2aDDJR\|UxKG:oIECuNVIh\|ryP	MXKyN\|YxOjV{Mx?=
High5	M3nMcGtqdmG\|ZTDBd5NigQ>?		MWCyOEBp		MlT5TY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDN{B4cXSqIFnDOVAhd2ZiMD6xO{DPxE1?	NFv4dGEzOzZyMkWyNy=>
A549	MmTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NHzyRopFVVOR	NVTrRph1UUN3ME2xMlA4QSEQvF2=	MkXtNlM3PDR{MUC=
HCT116	NYrVSm53T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			MkXISG1UVw>?	Mm[zTWM2OD1yLke1O{DPxE1?	M4GwOVI{PjR2MkGw
K562	NWT3SlNtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=			NXjyfo05TE2VTx?=	MXTJR\|UxRTBwNkS1JO69VQ>?	M3uxelI{PjR2MkGw
GBC-SD	M1PuUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M2TpVFUh\|ryP	NEXINoI4OiCq	MmjPSG1UVw>?	MU\JR\|UxRTF2Lkig{txO	M3HVN\|I{PzB5Mk[w
HGC27	M3[1WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NI\heVk2KM7:TR?=	MkXIO\|IhcA>?	NFzNNHhFVVOR	NE\McpJKSzVyPUWuOEDPxE1?	NFHvVW4zOzdyN{K2NC=>
HL60	MlfET4lv[XOnIFHzd4F6	NGeyNYE2KM7:TR?=	MViyOEBp	MXjEUXNQ	MWTJcohq[mm2aX;uJI9nKEiGQVO=	MYmyN\|cxPzJ4MB?=
Vero	M4jScGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NWLVVpNPPzJiaB?=	NGK3eHlFVVOR	MX3JR\|UxRTBwOTFOwG0>	MnixNlM4QDZ2NUK=
NCI60	NWW4XGl2S3m2b4TvfIlkKEG\|c3H5		NY\Qc2ptPDhiaB?=	M1nifWROW09?	NH6zUHNIUT1yLkWzJO69VQ>?	NWLxc29LOjRyMUWzNlc>
SW620	M2rURWN6fG:2b4jpZ{BCe3OjeR?=		MnvxOFghcA>?	MmmySG1UVw>?	NEHNOpdIUT1yLkW0JO69VQ>?	NGG2[oozPDBzNUOyOy=>
U251	MVLDfZRwfG:6aXOgRZN{[Xl?		M1zMeFQ5KGh?	M1jlcGROW09?	MYHHTV0yNjV\|IN88US=>	NEHQNlMzPDBzNUOyOy=>
KM12	NVnwOnF3S3m2b4TvfIlkKEG\|c3H5		NH3EZlk1QCCq	M3zZdmROW09?	NVjHTHRbT0l;MT64PEDPxE1?	NHGybYwzPDBzNUOyOy=>
Hs578T	NIj3SHREgXSxdH;4bYMhSXO\|YYm=		NImyU5c1QCCq	MofhSG1UVw>?	M3\k[mdKRTRwOEOg{txO	NVnNclZCOjRyMUWzNlc>
MDA-MB-231	M{LOc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M2Pl[lQ5KGh?		MXLJR\|UxRTBwMU[g{txO	MUOyOFA6PTBzNh?=
MCF7	NUfWemprT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIHwbFQ1QCCq		M1O1SWdKRTBwNEWg{txO	MX:yOFEyQTV3NR?=
MDA-MB-435	NIrmcohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MWW0PEBp		M1mwSWdKRTBwOEig{txO	M4fwWlI1OTF7NUW1
AsPC1	NGe5NXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3\KZ\|MxKM7:TR?=	MX20PEBp	MkHrSG1UVw>?	NXO4O49uUUN3ME2zMlY3KM7:TR?=	MXuyOFE5PTN5OB?=
Jurkat E6.1	MWPLbY5ie2ViQYPzZZk>		Mle1NkBp	MYDEUXNQ	M3LhfmlvcGmkaYTpc44hd2ZiSFTBR\|Qhf2m2aDDJR\|UxKG:oIECuNFQh\|ryP	NIjmXYgzPDJ4MUi2Ni=>
KG1	MnjqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MkHYOFghcA>?		M{m3fWlEPTB;MT6xOUDPxE1?	MmPpNlQ2OjVyMEO=
HEL	NGDIXY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX7JZlVFPDhiaB?=	MkXySG1UVw>?	NXXPSItJUUN3ME2wMlQ6KM7:TR?=	NVjPR\|d{OjR4OUSwOVU>
HSC3	NFrNWpZEgXSxdH;4bYMhSXO\|YYm=		MmewNVIhcA>?	MUDEUXNQ	MX\JR\|UxRTBwN{Gg{txO	NUHXOXM1OjR5Nk[1OlA>
HT-29	NEHWcphEgXSxdH;4bYMhSXO\|YYm=		M2KxZVEzKGh?	Mn32SG1UVw>?	M3j2bWlEPTB;MD63NkDPxE1?	M{D3eVI1PzZ4NU[w
KB	NVfrcFNpS3m2b4TvfIlkKEG\|c3H5		NWf1W2RHOTJiaB?=	M2HOcmROW09?	MV3JR\|UxRTBwN{Wg{txO	Ml;PNlQ4PjZ3NkC=
H460	NGHtdlhEgXSxdH;4bYMhSXO\|YYm=		MnvJNVIhcA>?	NGrDPYpFVVOR	M4nv[WlEPTB;MD64NkDPxE1?	MWGyOFc3PjV4MB?=
MONE1	M4T5d2N6fG:2b4jpZ{BCe3OjeR?=		NU[yNlBNOTJiaB?=	MWHEUXNQ	NVfZcGZpUUN3ME2xMlE5KM7:TR?=	MXiyOFc3PjV4MB?=
MKN45	MVvDfZRwfG:6aXOgRZN{[Xl?		MWKxNkBp	MnrjSG1UVw>?	M3HyOmlEPTB;MT6yOUDPxE1?	MUmyOFc3PjV4MB?=
TSGH	MYfDfZRwfG:6aXOgRZN{[Xl?		MYCxNkBp	NV3GXIV6TE2VTx?=	M4jmXGlEPTB;Mj6wPUDPxE1?	NIPFWG4zPDd4NkW2NC=>
HL60	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NULmUI9pPzJiaB?=	NFviS3hFVVOR	MnzyS2k2OD1yLkmzJO69VQ>?	MmW1NlQ6ODB3MEC=
HEK293	MoDES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NFzjToU4OiCq	NFjWbmNFVVOR	MoLMS2k2OD1zMzFOwG0>	M2Xx[FI1QTByNUCw
Jurkat	MVHDfZRwfG:6aXOgRZN{[Xl?	MlnDNVAxKM7:TR?=	NYrOdm53PzJiaB?=		MnTvS2k2OD1yLkmg{txO	M1XGTVI1QTByN{Sz
GM15850	NInaOIlMcW6jc3WgRZN{[Xl?	MV[yMlUh\|ryP	MY[5OkBp	M3rScmROW09?	M3fxcIRw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg{KGy7c3nu[UAyPCCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>	M1LVOlE3QTJzM{[3
GM15850	NG\MVZhMcW6jc3WgRZN{[Xl?	M3PQfFIvPSEQvF2=	MknaPVYhcA>?	MYPEUXNQ	NUDPV5hr\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDRibInzbY5mKDViYXPleJlt[XSrb36gc4YhTliQIHflcoU>	MnPMNVY6OjF\|Nke=
GM15850	M2q3Z2tqdmG\|ZTDBd5NigQ>?	Mnq1Nk42KM7:TR?=	M1zIVlk3KGh?	NGnlR5lFVVOR	NGL3Sppld2W\|IH7veEBqdmirYnn0JGhFSUNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hcGm\|dH;u[UBJPCCueYPpcoUhOTJiYXPleJlt[XSrb36gc4YhTliQIHflcoU>	M{LVflE3QTJzM{[3
GM15850	M1rDeWtqdmG\|ZTDBd5NigQ>?	NGD5RpQzNjVizszN	NVHzcINOQTZiaB?=	M3H5TmROW09?	NVG4OXRm\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDNibInzbY5mKDliYXPleJlt[XSrb36gc4YhTliQIHflcoU>	NVnoN5dFOTZ7MkGzOlc>
GM15850	NH3TTFNMcW6jc3WgRZN{[Xl?	MVqyMlUh\|ryP	M3zMVVk3KGh?	NYGwVmRETE2VTx?=	NGm2Wopld2W\|IH7veEBqdmirYnn0JGhFSUNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hcGm\|dH;u[UBJPCCueYPpcoUhQCCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>	M1\kVFE3QTJzM{[3
GM15850	NFnpeHNMcW6jc3WgRZN{[Xl?	MmjyNk42KM7:TR?=	M3PaT\|k3KGh?	M3T6[WROW09?	M1rkXoRw\XNibn;0JIlvcGmkaYSgTGRCSyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBpcXO2b37lJGg1KGy7c3nu[UAyPiCjY3X0fYxifGmxbjDv[kBHYE5iZ3Xu[S=>	MXGxOlkzOTN4Nx?=
GM15850	MX3GeY5kfGmxbjDBd5NigQ>?	M3XyXFUh\|ryP	MkTENVIhcA>?	M{\GXmROW09?	NG\LO3Jp[XNibn:g[YZn\WO2IH;uJGZZViCvUl7BJIV5eHKnc4Ppc44>	NYDU[4d7OTZ7MkGzOlc>
U937	MorMT4lv[XOnIFHzd4F6	NFTueIo2KM7:TR?=	MmP4NlQhcA>?	NHXBN4pFVVOR	NHLMR\|Np[XNibn:g[YZn\WO2IH;uJIFteGijIIT1ZpVtcW5iYXPleJlt[XSrb36=	MknhNVc1PDd5NUC=
U937	M2nnR2tqdmG\|ZTDBd5NigQ>?	M1LYU\|Eh\|ryP	MoLsNlQhcA>?	MUjEUXNQ	MXjoZZMhdm9iZX\m[YN1KG:wIHHsdIhiKHS3YoXsbY4h[WOndInsZZRqd25?	MWGxO\|Q1Pzd3MB?=
PANC1	NYXZPXVnTnWwY4Tpc44hSXO\|YYm=	MYGxJO69VQ>?	M13aeVI1KGh?		MXvkc4V{KG6xdDDpcoNz\WG\|ZTDpckBxOjetaYCxJIdmdmViZYjwdoV{e2mxbh?=	MVGxO\|U5QDd2NB?=
PANC1	M1;tdGZ2dmO2aX;uJGF{e2G7	NEW5SGMyKM7:TR?=	MljTOFghKGh?		MX7kc4V{KG6xdDDpcoNz\WG\|ZTDpckBxOjetaYCxJIdmdmViZYjwdoV{e2mxbh?=	MXSxO\|U5QDd2NB?=
Caco-2	M1jNfGZ2dmO2aX;uJGF{e2G7	NEXtTIk2KM7:TR?=	MWKyOEBp	MnPNSG1UVw>?	MVrkc4V{KG6xdDDpcoR2[2ViUEKxW2FHOSCpZX7lJIV5eHKnc4Ppc44>	M2G1blIxOTR\|OESw
SCC4	M3vmU2Z2dmO2aX;uJGF{e2G7	MlvXNUDPxE1?	NYDkNldVOTBibXnu	MULEUXNQ	MXLoZZMhdm9iYXfvcol{fCCjY4Tpeol1gSCjdDDWSHIh[XO\|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJGN[WDJ2IHflcoUh\XiycnXzd4lwdg>?	MoO2NlA1PTJ{MkW=
A549	NV7LUnZjTnWwY4Tpc44hSXO\|YYm=	MVy1JO69VQ>?	NHu4fYc{KGh?	M4\pOmROW09?	MXjkc4V{KG6xdDDpcoR2[2ViYYX0c5Bp[We7IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEyFM1nJ	M2DLbVIxQDV3MkC4
HCT116	MVvLbY5ie2ViQYPzZZk>	MlGwNE4{KM7:TR?=	NIHDVHc{OCCq	MYLEUXNQ	NF3hNG1ld2W\|IH7veEBqdmirYnn0JGhFSUNzIHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCqaYP0c45mKEh\|S{mgZYNmfHmuYYTpc44>	Ml\yNlExQDB4NEe=
HepG2	NHzwXndHfW6ldHnvckBCe3OjeR?=	NETUTWIyOCEQvF2=	NWO2U215OjRiaB?=	MYnEUXNQ	MmXk[I9meyCwb4SgbY5lfWOnIHHwc5B1d3OrczDhd5Nme3OnZDDhd{BpgXCncnHj[ZR6dGG2aX;uJI9nKHB3Mx?=	MVWyNVU1QDV6Mh?=
GM11272	NFzYW5VHfW6ldHnvckBCe3OjeR?=	NGPEVHgxNjFizszN	NHnrVY04OiCq	NFLYNZNFVVOR	M1jiRoRw\XNibn;0JJJm[WO2aY\heIUhVWWFcEKgcZV1[W62IHX4dJJme3Orb36=	NIjKV5EzOTh2MEexOi=>
MDA-MB-231	MWnLbY5ie2ViQYPzZZk>	M1HKXlExKM7:TR?=	M1ThbVUhdWmw	MofKSG1UVw>?	NV;kVY42\G:nczDuc5QhcW6qaXLpeEBJTEGFMnG=	M3[2clI{PDl\|NES5
MDA-MB-231	MUDLbY5ie2ViQYPzZZk>	M4rIdFEh\|ryP	M3vON\|I1KGh?	NX;nNXVOTE2VTx?=	NV\lXHdN\G:nczDuc5QhcW6qaXLpeEBJTEGFNjDhd5Nme3OnZDDhd{Bi[2W2eXzheIlwdiCuZY\lcJMhd2ZidIXieYxqdg>?	NWrYU2o2OjN2OUO0OFk>
K562	MkDsT4lv[XOnIFHzd4F6				MWXkc4V{KG6xdDDpcohq[mm2IFjERWM>	NIrjRoIzOzV7MUGxNS=>
Jurkat	Ml75R5l1d3SxeHnjJGF{e2G7	NX\Od2dUOjBizszN	MUO3NkBp	MYfEUXNQ	Mn32co8h[3m2b4TvfIlkcXS7IHHzd4V{e2WmIHHzJIdzd3e2aDDpcohq[mm2aX;u	MYGyOFMxPDN2OB?=
HCT116	NYO3T5hESXCxcITvd4l{KEG\|c3H5	MmftN{DPxE1?	MoLpNlQhcA>?	NVfjNW5TTE2VTx?=	MXvkc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m\|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKHB3MzDwdo91\WmwIHzleoVt	M3uySVI1PzZ4NU[w
KASUMI-1	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVXRbIdoUUN3ME25PU4yPyCwTR?=	NHf5OGFUSU6JRWK=
KARPAS-45	MnriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUXUOYV5UUN3ME2xO\|MvQDlibl2=	NVXjUXRwW0GQR1XS
BHT-101	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVm5R2RmUUN3ME2yOFQvOThibl2=	NUf2cFVFW0GQR1XS
H9	M{nVcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVrrZ3NMUUN3ME2yOVUvODRibl2=	M1v6U3NCVkeHUh?=
PA-1	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWLJR\|UxRTJ6Nj6yOkBvVQ>?	NE\4TJNUSU6JRWK=
NEC8	NInZUnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHv5eG5KSzVyPUK4PU4{QCCwTR?=	NWS3Z41xW0GQR1XS
MHH-PREB-1	Ml3vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVTCb2NtUUN3ME2yPVQvPTNibl2=	NXL2SYk6W0GQR1XS
NB7	NVvOfFZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3jKNGlEPTB;M{S1Mlc1KG6P	MV3TRW5ITVJ?
A3-KAW	NUT4eYVuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF7lU\|lKSzVyPUSwNE42QSCwTR?=	Mk\qV2FPT0WU
NB69	NUixbW1XT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlexTWM2OD12MUGuO\|Ehdk1?	MXrTRW5ITVJ?
EoL-1-cell	NInqd21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmPFTWM2OD12NUSyOUBvVQ>?	M2jCbnNCVkeHUh?=
CHP-212	NWC3PXQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Ml2wTWM2OD12NUeuOVMhdk1?	MkLOV2FPT0WU
C2BBe1	MnXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3nZXWlEPTB;NEeyMlE6KG6P	NFiwfXVUSU6JRWK=
697	NYPPUFl7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGPaSGhKSzVyPUS3N{41OSCwTR?=	MVrTRW5ITVJ?
BCPAP	M4fMPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF3ZU2RKSzVyPUWwNU41OiCwTR?=	NHKzdFZUSU6JRWK=
L-363	MmHSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVfyeFN5UUN3ME21NFMvOSCwTR?=	NF7LN3BUSU6JRWK=
ES8	M4LiTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1jYdmlEPTB;NUKzMlU{KG6P	MV7TRW5ITVJ?
BE-13	MonaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkX0TWM2OD13Mk[uPVYhdk1?	NFPU[ItUSU6JRWK=
CTB-1	NWL1S\|RQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4LtV2lEPTB;NUO3MlkzKG6P	NHXm[XZUSU6JRWK=
HD-MY-Z	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWr2VI9oUUN3ME21N\|gvOTNibl2=	NVK3UVg6W0GQR1XS
NKM-1	MofBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF3xUmhKSzVyPUW0OE4zPyCwTR?=	MUDTRW5ITVJ?
NCI-H720	NVPwWYhRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXvJR\|UxRTV4MD6xPEBvVQ>?	MkPIV2FPT0WU
KY821	Mn;6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnLYTWM2OD13NkOuNlUhdk1?	NFLv[\|FUSU6JRWK=
OVCAR-5	NF\GVoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4q1NGlEPTB;NUe2MlEyKG6P	NXvYdVkxW0GQR1XS
CTV-1	M4jy[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWXu[5VHUUN3ME21PFEvPTZibl2=	NHfmV4dUSU6JRWK=
P12-ICHIKAWA	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2TYc2lEPTB;NUm2MlUyKG6P	Mnm5V2FPT0WU
DB	MmrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVLJR\|UxRTV7OD61O{BvVQ>?	M3ToXHNCVkeHUh?=
CHL-1	NYrLTmdOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX7JR\|UxRTZ2Mj6wPEBvVQ>?	MVPTRW5ITVJ?
A4-Fuk	NELmdmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWDJR\|UxRTZ2ND65NUBvVQ>?	NV3ue4pvW0GQR1XS
MV-4-11	NFvPWnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4rxSGlEPTB;NkW5MlEhdk1?	NEK3fZdUSU6JRWK=
RPMI-8226	NFrvc5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWX5elFxUUN3ME22O\|gvOThibl2=	MlvlV2FPT0WU
NB14	NX;xV4RkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Moe4TWM2OD14OU[uPVUhdk1?	MY\TRW5ITVJ?
DOHH-2	NEP3S5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEKxOm1KSzVyPUewOk43QCCwTR?=	Mn3lV2FPT0WU
D-423MG	NEfUdWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV\2UJJHUUN3ME23NFYvQDlibl2=	MW\TRW5ITVJ?
D-283MED	M3\5UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXXJR\|UxRTdzND6xOEBvVQ>?	MlyzV2FPT0WU
ES1	NV7mRnBQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoPpTWM2OD15MkSuOEBvVQ>?	M2DPUnNCVkeHUh?=
GOTO	NV;hdYRTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXnLXlliUUN3ME23NlkvOTJibl2=	M1;YSHNCVkeHUh?=
NCI-H209	MoPWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1vJfGlEPTB;N{K5Mlkhdk1?	M2XWXHNCVkeHUh?=
MOLT-13	MkS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX;JR\|UxRTd\|OD65PEBvVQ>?	MV;TRW5ITVJ?
ATN-1	MkTMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVvJR\|UxRTd2MD6yPEBvVQ>?	MnfCV2FPT0WU
DU-4475	NHrMZ2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHOw[mFKSzVyPUe1NU46OSCwTR?=	M4XTRnNCVkeHUh?=
NB10	NFKzeZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWrJR\|UxRTd3MT65NkBvVQ>?	MX7TRW5ITVJ?
KG-1	M2XTN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{HFbmlEPTB;N{e1MlQ2KG6P	MVnTRW5ITVJ?
MOLT-4	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYrJR\|UxRTd6Nz60OkBvVQ>?	MVXTRW5ITVJ?
TE-1	NU[xVWM1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1HqRWlEPTB;N{mxMlEhdk1?	MnT2V2FPT0WU
SBC-1	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWnyS45nUUN3ME23PVMvQDRibl2=	MXvTRW5ITVJ?
HEL	MlLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUPJR\|UxRThyNj6wPEBvVQ>?	M1rnR3NCVkeHUh?=
SK-MEL-2	M3u5Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX[5WXc4UUN3ME24NFkvPDRibl2=	Mkj3V2FPT0WU
KU812	Ml60S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NETxW\|FKSzVyPUixN{4yKG6P	NUjQNYREW0GQR1XS
RPMI-8866	NFe5SYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3rSSGlEPTB;OEGzMlY4KG6P	MlrtV2FPT0WU
ALL-PO	M3vacGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV3ONlJGUUN3ME24NVQvPjZibl2=	NWPJWJZZW0GQR1XS
LU-139	NYjPZ406T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVnkdGU{UUN3ME24NlIvQDZibl2=	MYrTRW5ITVJ?
RS4-11	MoH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3jwOWlEPTB;OEOyMlQ2KG6P	M3z6RXNCVkeHUh?=
EW-18	MkXlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFHmeXBKSzVyPUizNk46PiCwTR?=	M1q3U3NCVkeHUh?=
P30-OHK	MlvOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUHJR\|UxRTh\|NT63JI5O	NY\qZpFoW0GQR1XS
D-566MG	Mmi0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2eyXGlEPTB;OEO4MlYzKG6P	MmXXV2FPT0WU
HSC-4	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mmi5TWM2OD16NE[uOVEhdk1?	MnfEV2FPT0WU
QIMR-WIL	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlHTTWM2OD16NkKuNFMhdk1?	M3PWZ3NCVkeHUh?=
SW954	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmToTWM2OD16NkOuNVYhdk1?	NFrQVmhUSU6JRWK=
HGC-27	NEXS[VFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGLje2dKSzVyPUi3Nk4{PCCwTR?=	NWG5TG9wW0GQR1XS
HH	M{mxUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGnaUINKSzVyPUi5OE4yOiCwTR?=	MVfTRW5ITVJ?
KE-37	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3vKXWlEPTB;OEm0MlYzKG6P	MYHTRW5ITVJ?
SK-N-DZ	M{\iNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{XUbGlEPTB;OUCwMlQ{KG6P	MWTTRW5ITVJ?
J-RT3-T3-5	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVHNPHpsUUN3ME25NVAvPDlibl2=	NYTUS2V1W0GQR1XS
A427	M2PYN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX24R3JmUUN3ME25NlAvQDRibl2=	NYH1TnU2W0GQR1XS
ECC10	Mo\US5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4iyNWlEPTB;OUS1Mlg4KG6P	M1rQ[XNCVkeHUh?=
EW-1	M2npbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlrzTWM2OD17NEeuNlYhdk1?	MVTTRW5ITVJ?
MIA-PaCa-2	MnXGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHHielNKSzVyPUm0PU4yOiCwTR?=	NFfzWYdUSU6JRWK=
HCC2218	M2rve2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2jaZ2lEPTB;OUW4MlQ5KG6P	NYDIXZBOW0GQR1XS
HAL-01	M4\CfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHT3TpRKSzVyPUm2PE4xPCCwTR?=	M2jpZ3NCVkeHUh?=
RD	NX3L[FA{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXnOUHZMUUN3ME25O\|QvPDVibl2=	NY\GUXVvW0GQR1XS
SK-N-AS	MlL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIf1[ZdKSzVyPUm4PE4yKG6P	Mn7ZV2FPT0WU
ML-2	NHvMRWZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYrJR\|UxRTFwMEC0NFch\|ryP	MVfTRW5ITVJ?
MEL-HO	M4X1cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{L1dmlEPTB;MT6wNFU5OiEQvF2=	NIS5SlRUSU6JRWK=
MS-1	M4PZWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M33LWmlEPTB;MT6wNFYyPyEQvF2=	NEnId5RUSU6JRWK=
NCI-SNU-1	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkL4TWM2OD1zLkCyN\|MyKM7:TR?=	MY\TRW5ITVJ?
8505C	M3Tj[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUXoNHhkUUN3ME2xMlAzOzNzIN88US=>	NGjRO3FUSU6JRWK=
MN-60	Mn33S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3TWbGlEPTB;MT6wNlY5KM7:TR?=	MVPTRW5ITVJ?
SAS	M{DDWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHrYeGxKSzVyPUGuNFQxQDFizszN	NGfUbnFUSU6JRWK=
EFM-19	M2fRU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX7FcYRpUUN3ME2xMlA1QDd7IN88US=>	MVvTRW5ITVJ?
Ca9-22	NFjhT5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2XBPGlEPTB;MT6wOVExPyEQvF2=	MlLuV2FPT0WU
NBsusSR	NVu3TlRZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIrjWYFKSzVyPUGuNFUyPjZizszN	MV\TRW5ITVJ?
NB13	NIm3fXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnHuTWM2OD1zLkC1OVAyKM7:TR?=	NULu[JNFW0GQR1XS
SF295	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkLzTWM2OD1zLkC2OlI1KM7:TR?=	NFWwcG1USU6JRWK=
U-2-OS	NY\D[\|ZtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1S4OWlEPTB;MT6wO\|kyOSEQvF2=	NF7OcWZUSU6JRWK=
NCI-H526	NYnobllTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYjJR\|UxRTFwMEiyPVEh\|ryP	NY[ycnVCW0GQR1XS
KMOE-2	NEH2TWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWfJR\|UxRTFwMEm0NlIh\|ryP	NGPpeGtUSU6JRWK=
RCM-1	NIfJPIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkGyTWM2OD1zLkGyNVAzKM7:TR?=	Ml\HV2FPT0WU
MC116	NXzDSmVUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2rKUWlEPTB;MT6xN\|YzOSEQvF2=	NUG5[od5W0GQR1XS
NCI-H1092	Mne3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXfJR\|UxRTFwMUW0NFYh\|ryP	NVn1dnNWW0GQR1XS
EW-3	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVr4Xms2UUN3ME2xMlE4OjF{IN88US=>	NVj5ZYloW0GQR1XS
HCT-116	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlfUTWM2OD1zLkG3O\|Uh\|ryP	NXrIS5R3W0GQR1XS
MC-IXC	MkLaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3rtT2lEPTB;MT6xO\|g5OSEQvF2=	M4jRNnNCVkeHUh?=
LB1047-RCC	NWPWPJpQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MofJTWM2OD1zLkG4N\|EzKM7:TR?=	MkflV2FPT0WU
VM-CUB-1	MonES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{PXNWlEPTB;MT6xPVExQCEQvF2=	NVP1bmJCW0GQR1XS
NB5	MmHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWDJR\|UxRTFwMUm4OVYh\|ryP	NFr4dZFUSU6JRWK=
SKG-IIIa	NF;pZ3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MljCTWM2OD1zLkKzOFY1KM7:TR?=	NEnjWItUSU6JRWK=
HO-1-N-1	NXK0Vmt2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWTJR\|UxRTFwMkO4N\|Uh\|ryP	NHPt[mpUSU6JRWK=
EFO-27	Mlf4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYTJR\|UxRTFwMkWwOFMh\|ryP	M1TiU3NCVkeHUh?=
MHH-NB-11	NYrHTHNwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4H1S2lEPTB;MT6yPFMzQSEQvF2=	M17PZ3NCVkeHUh?=
SW620	MkPBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUDJR\|UxRTFwMkmwNVgh\|ryP	NH\1UnNUSU6JRWK=
MOLT-16	NXT0Vng3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoDSTWM2OD1zLkK5O\|k4KM7:TR?=	NHL5PXFUSU6JRWK=
NTERA-S-cl-D1	MlP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWjJR\|UxRTFwM{G3OlEh\|ryP	NWD3WYRFW0GQR1XS
VA-ES-BJ	Mnr5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{O4WmlEPTB;MT6zNlQ4PyEQvF2=	Mmj0V2FPT0WU
HCC1419	NH;m[ZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NI[3To9KSzVyPUGuN\|QxOjdizszN	MWPTRW5ITVJ?
NCI-H69	M{TEVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml23TWM2OD1zLkO0NVEzKM7:TR?=	NUXD[20zW0GQR1XS
DEL	NGrROWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXjuNVJuUUN3ME2xMlM2OTZ{IN88US=>	M{DUdnNCVkeHUh?=
LXF-289	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVPXUJBXUUN3ME2xMlM2OjRizszN	M2rFR3NCVkeHUh?=
EW-11	M3\RW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHzHWJNKSzVyPUGuN\|YxOjZizszN	MlHEV2FPT0WU
KP-4	NIf0[HZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWDKbotqUUN3ME2xMlM4ODh3IN88US=>	NUHPbYdQW0GQR1XS
NOS-1	NYH3SVJlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTFwNEGxPVQh\|ryP	NXzmVGxiW0GQR1XS
SK-NEP-1	M2fVU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkniTWM2OD1zLkSxOlk{KM7:TR?=	M1LxfXNCVkeHUh?=
LAMA-84	MkPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF30U2VKSzVyPUGuOFM6PDVizszN	MWXTRW5ITVJ?
ES5	NHL6OWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVOyNYpYUUN3ME2xMlQ1OyEQvF2=	MUXTRW5ITVJ?
HuO9	MnvGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVnJR\|UxRTFwNEWzOlIh\|ryP	MkH4V2FPT0WU
COLO-684	M3G1fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVOwRnBDUUN3ME2xMlQ3OTF6IN88US=>	MUnTRW5ITVJ?
EW-24	M3XaXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MojYTWM2OD1zLkS2OVMyKM7:TR?=	MmLjV2FPT0WU
BV-173	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXfJR\|UxRTFwNEeyPVEh\|ryP	NXTXVpA4W0GQR1XS
NCI-H1770	M1TGfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnrjTWM2OD1zLkS4OVM3KM7:TR?=	MXnTRW5ITVJ?
HuP-T4	M33MW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{LPfWlEPTB;MT60PVMh\|ryP	M3;DcnNCVkeHUh?=
TYK-nu	NFe3dnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGn6dJFKSzVyPUGuOFk5PTFizszN	M2\RVnNCVkeHUh?=
YH-13	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXXJR\|UxRTFwNEm4PVQh\|ryP	NWfsT4k2W0GQR1XS
H4	NHfLOHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHLvSItKSzVyPUGuOVA6OTJizszN	NH7sR5BUSU6JRWK=
OVCAR-8	M{DxTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4HQOmlEPTB;MT61OFQ4PyEQvF2=	NVvMRnF1W0GQR1XS
NCI-H23	NULVfYN4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUDtcHV5UUN3ME2xMlU1PjR3IN88US=>	NGP1bXNUSU6JRWK=
ES7	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVvJR\|UxRTFwNUS3O\|Mh\|ryP	M{\DT3NCVkeHUh?=
COR-L88	NFTneFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFLQXpZKSzVyPUGuOVY1OjRizszN	MX\TRW5ITVJ?
TI-73	M4nURmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2TudWlEPTB;MT61PVA3KM7:TR?=	NVyyXHFzW0GQR1XS
RT-112	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFTKXnVKSzVyPUGuOVkzQDRizszN	MYfTRW5ITVJ?
HuO-3N1	Mn3OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWTJR\|UxRTFwNUmzPFUh\|ryP	NHjXe5hUSU6JRWK=
HC-1	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{TBdGlEPTB;MT61PVg3PiEQvF2=	NVHW[Fd[W0GQR1XS
HT55	M4ruVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3PJNmlEPTB;MT62OVE{OSEQvF2=	M{jn[3NCVkeHUh?=
IA-LM	NF3VOotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIiz[G1KSzVyPUGuOlkzPzhizszN	NX3OXVFnW0GQR1XS
EM-2	M2rlT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3rqWmlEPTB;MT63NFAyPCEQvF2=	MmDxV2FPT0WU
MHH-ES-1	NWrTcYVyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnjkTWM2OD1zLkewOFM2KM7:TR?=	MYDTRW5ITVJ?
CAL-27	NXnOSXVuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M13QeWlEPTB;MT63NFYzOSEQvF2=	MoHqV2FPT0WU
COLO-800	Mnn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYrJR\|UxRTFwN{GxO\|kh\|ryP	MWrTRW5ITVJ?
HCE-T	M{DTVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2jxVmlEPTB;MT63NVUh\|ryP	M3rWfHNCVkeHUh?=
CAMA-1	NFnIV3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXrCWXJFUUN3ME2xMlcyQTdzIN88US=>	NIi0cmJUSU6JRWK=
LOXIMVI	NV\JOZBwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlrXTWM2OD1zLkeyNVEh\|ryP	M2P2b3NCVkeHUh?=
NH-12	NXu4N2RMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1n0[mlEPTB;MT63NlY6OSEQvF2=	M3vSRXNCVkeHUh?=
TCCSUP	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVrJR\|UxRTFwN{K4Nlkh\|ryP	NYTQcnk3W0GQR1XS
MDA-MB-361	MmnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVPx[mJqUUN3ME2xMlc{OTV5IN88US=>	MWXTRW5ITVJ?
EW-16	M2DMc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mkn5TWM2OD1zLke0NVA4KM7:TR?=	NYWwSnVvW0GQR1XS
SNU-423	NFLxXlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3jMWWlEPTB;MT63OVgzPyEQvF2=	MlLPV2FPT0WU
Daoy	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEC1O2FKSzVyPUGuO\|Y{OTlizszN	MYHTRW5ITVJ?
ES4	MoTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkTJTWM2OD1zLke4O\|QyKM7:TR?=	M1\kc3NCVkeHUh?=
PFSK-1	M4C3Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmfRTWM2OD1zLkiwN\|ch\|ryP	MlW2V2FPT0WU
ES3	NHG0TnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVq3Om1qUUN3ME2xMlgzPjhzIN88US=>	NGXac5ZUSU6JRWK=
ONS-76	Mn23S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1fjNmlEPTB;MT64Nlg6PyEQvF2=	NU\WSVY3W0GQR1XS
JVM-3	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnyzTWM2OD1zLki1OFUyKM7:TR?=	NHLtVG1USU6JRWK=
OS-RC-2	NWrSfJdoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFzwVJBKSzVyPUGuPFcyPTFizszN	M4S5U3NCVkeHUh?=
COLO-320-HSR	NWPQdYV[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHzPU3BKSzVyPUGuPFgyQTdizszN	NFTnb3dUSU6JRWK=
HN	NHm4UZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVf6OpVFUUN3ME2xMlg5PzJ3IN88US=>	NYfKRm1wW0GQR1XS
HT	NXXmOZZGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4DmeGlEPTB;MT64PFk1PyEQvF2=	NYjQVHhNW0GQR1XS
LoVo	NXXQUoVGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NETxS21KSzVyPUGuPFk5OSEQvF2=	MWfTRW5ITVJ?
CGTH-W-1	NFnUXYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFHOXlVKSzVyPUGuPFk6PDZizszN	M4PhWnNCVkeHUh?=
NB6	NE\PSZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{\mN2lEPTB;MT65NVI6QCEQvF2=	NH7IXYhUSU6JRWK=
EW-22	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHn5OXlKSzVyPUGuPVI5QDdizszN	MonWV2FPT0WU
ES6	NXfQUm1nT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFPCb45KSzVyPUGuPVM3OzFizszN	M{XHPHNCVkeHUh?=
SCC-15	Mo\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEXBWmRKSzVyPUGuPVM5OTlizszN	NUj2W2RZW0GQR1XS
HL-60	NWXsenA1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHv2cXlKSzVyPUGuPVM6ODJizszN	NYTXNnNsW0GQR1XS
human HOP-92	NYHUVIpDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVTxSVgxUUN3ME2xMlk1ODZ3IN88US=>	NH;MOnpUSU6JRWK=
SW626	NV[4fHdXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXTJR\|UxRTFwOUS4PVkh\|ryP	NW\sUYs{W0GQR1XS
HEC-1	NET3bVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NILsbVZKSzVyPUGuPVU{PiEQvF2=	NX7L[YFEW0GQR1XS
LB2241-RCC	M4DMfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NETzcGxKSzVyPUGuPVgzOzFizszN	MV;TRW5ITVJ?
Ramos-2G6-4C10	M3fxe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXixfph[UUN3ME2xMlk6PDl\|IN88US=>	NFjE[\|hUSU6JRWK=
A101D	NIK1OWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4fwR2lEPTB;Mj6yNFMxOyEQvF2=	NXriSIVGW0GQR1XS
NCI-H446	M2fqUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXnjU\|ZtUUN3ME2yMlA1PTl7IN88US=>	MYLTRW5ITVJ?
SBC-5	Mlu0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUDvSWgzUUN3ME2yMlA3OTR5IN88US=>	MY\TRW5ITVJ?
HOS	MoTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXnJR\|UxRTJwMEe2OVMh\|ryP	NUn2O2d6W0GQR1XS
K5	MlzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYjJR\|UxRTJwMEe4NVEh\|ryP	M{Lxe3NCVkeHUh?=
HLE	NXOzV4hWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MULJR\|UxRTJwMEi1Nlkh\|ryP	M3ntSXNCVkeHUh?=
HSC-2	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoDhTWM2OD1{LkGyPFk5KM7:TR?=	Mlf2V2FPT0WU
LCLC-97TM1	M{\jbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGXrSWRKSzVyPUKuNVQ2QDNizszN	NEnnSYxUSU6JRWK=
DMS-273	NFP1PZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmDnTWM2OD1{LkG0PFM4KM7:TR?=	M4rxTHNCVkeHUh?=
TE-8	Mkn5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEDOe5NKSzVyPUKuNVU4PjVizszN	NX3CR5NpW0GQR1XS
DSH1	M2jYdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4ewZWlEPTB;Mj6xOlM6QCEQvF2=	MkX2V2FPT0WU
CAL-51	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWfxT5Z7UUN3ME2yMlE3Pjl7IN88US=>	MWjTRW5ITVJ?
IST-SL1	M1vyU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1iwOGlEPTB;Mj6xOlg1PCEQvF2=	NXfQN3U4W0GQR1XS
GCT	M1rIW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4jyfmlEPTB;Mj6xO\|c4KM7:TR?=	NHnBWIVUSU6JRWK=
SW948	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGjqbldKSzVyPUKuNVg1PTZizszN	MUXTRW5ITVJ?
NOMO-1	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVnJR\|UxRTJwMUmzNVch\|ryP	NYHseFlCW0GQR1XS
C8166	MkHyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV3JR\|UxRTJwMkGzN\|Qh\|ryP	MlrTV2FPT0WU
OC-314	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIfBZZZKSzVyPUKuNlMzPTlizszN	M1fzcHNCVkeHUh?=
CAL-39	M{L4cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVW5SWhOUUN3ME2yMlI{PjJ4IN88US=>	MlKwV2FPT0WU
MDA-MB-453	NHrkU\|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWDmO211UUN3ME2yMlI1Ojd3IN88US=>	M{HWV3NCVkeHUh?=
A673	M3TjcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX3QVFJbUUN3ME2yMlI2QDZ{IN88US=>	NXfhXFA2W0GQR1XS
HTC-C3	M3z0OGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1HiN2lEPTB;Mj6yOlg2KM7:TR?=	MkDsV2FPT0WU
NCI-H1666	NFfLcYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3f2[mlEPTB;Mj6yPFEyOSEQvF2=	NG\HbWpUSU6JRWK=
PSN1	M{DCZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYnJR\|UxRTJwMki5NVMh\|ryP	MYLTRW5ITVJ?
GI-1	Moj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHTJOGJKSzVyPUKuN\|A2PDNizszN	NWP1[FFEW0GQR1XS
HuH-7	MkDoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYe5UVRNUUN3ME2yMlMxPjN5IN88US=>	NX\0[FlrW0GQR1XS
JAR	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUTJR\|UxRTJwM{G5PFch\|ryP	M37LdHNCVkeHUh?=
5637	MmnYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWHQTGp[UUN3ME2yMlMzOTJ7IN88US=>	M{Hx[nNCVkeHUh?=
GB-1	NVP4V204T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoCyTWM2OD1{LkOyN\|M2KM7:TR?=	M3HyS3NCVkeHUh?=
KP-N-YS	MlfoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{TNPWlEPTB;Mj6zNlYyPSEQvF2=	M{DCbHNCVkeHUh?=
OAW-42	NVGxXGxpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF\tfVJKSzVyPUKuN\|M1OTZizszN	NIXj[GNUSU6JRWK=
8-MG-BA	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFfSSHRKSzVyPUKuN\|M6ODZizszN	NHfKPXlUSU6JRWK=
RH-18	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3TjcWlEPTB;Mj6zOVAzOiEQvF2=	NUPuNmQ6W0GQR1XS
NCI-H1155	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn7iTWM2OD1{LkO2O\|I2KM7:TR?=	Mo\xV2FPT0WU
NB17	MonPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUnJR\|UxRTJwM{iyOFMh\|ryP	NEe4WZFUSU6JRWK=
NCI-H1437	NFPKS\|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYfJR\|UxRTJwNEG4O\|Mh\|ryP	MVnTRW5ITVJ?
SN12C	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NG[yTGlKSzVyPUKuOFMzOTRizszN	MnHyV2FPT0WU
HSC-3	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIPTOGNKSzVyPUKuOFQ2ODlizszN	MWfTRW5ITVJ?
GAMG	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXrnd3ZmUUN3ME2yMlQ1PTZzIN88US=>	NEjVdmNUSU6JRWK=
HT-1080	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXHJR\|UxRTJwNES4OlQh\|ryP	NWnwUXdvW0GQR1XS
A549	Mmn4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3;mUGlEPTB;Mj60OFg6OyEQvF2=	MX\TRW5ITVJ?
KNS-62	MnPxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVXJR\|UxRTJwNEWwOlEh\|ryP	MmC2V2FPT0WU
YKG-1	NF;FOJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEPm[GdKSzVyPUKuOFU1OzdizszN	M{DReXNCVkeHUh?=
LU-134-A	NVr3TndqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkfNTWM2OD1{LkS3NFA5KM7:TR?=	NWLyWYczW0GQR1XS
FADU	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M33W[WlEPTB;Mj60O\|E3OiEQvF2=	NX7CR5htW0GQR1XS
TGBC11TKB	NIDJcpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{XHPGlEPTB;Mj60O\|E4PyEQvF2=	MYTTRW5ITVJ?
HT-3	NFvBZW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2f3R2lEPTB;Mj60PVU{PSEQvF2=	NELXSXdUSU6JRWK=
NCI-H2170	MnLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkPYTWM2OD1{LkWwOVQ6KM7:TR?=	NYrMfmw4W0GQR1XS
Mo-T	Ml\MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVTJR\|UxRTJwNUC5Nlch\|ryP	NF;KcJZUSU6JRWK=
CCRF-CEM	NGiwZ2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2fzWmlEPTB;Mj61N\|A1OyEQvF2=	MX\TRW5ITVJ?
KU-19-19	NFTYWnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1\NOGlEPTB;Mj61N\|UyOyEQvF2=	NGTrZm1USU6JRWK=
NCI-H1048	NHn2c29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MonPTWM2OD1{LkW1NFI2KM7:TR?=	M{XsOnNCVkeHUh?=
KOSC-2	NEXP[3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIrpfY9KSzVyPUKuOVYxPzZizszN	NF7kepBUSU6JRWK=
A431	M2j5bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEfoXlFKSzVyPUKuOVY{OzVizszN	M1zPOHNCVkeHUh?=
COR-L23	Ml7SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEPofG1KSzVyPUKuOVg2PjZizszN	MoXVV2FPT0WU
MKN28	Mo[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUjJR\|UxRTJwNUmwN\|ch\|ryP	NVe4UWIzW0GQR1XS
22RV1	M1\a[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkflTWM2OD1{LkW5Nlc1KM7:TR?=	MUjTRW5ITVJ?
ABC-1	NUW0UnBlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MY\JR\|UxRTJwNkC0OkDPxE1?	NG\QRlJUSU6JRWK=
NCI-H2126	NHTUOHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUm5eZhZUUN3ME2yMlYxQTh2IN88US=>	Mor1V2FPT0WU
DoTc2-4510	M4PaO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUnJR\|UxRTJwNkKxPFUh\|ryP	MVnTRW5ITVJ?
SCC-4	NUXRb3huT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MknzTWM2OD1{Lk[zNFEzKM7:TR?=	MVHTRW5ITVJ?
NCI-H661	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX3HepU4UUN3ME2yMlY1ODh3IN88US=>	Mn\XV2FPT0WU
RPMI-2650	NYL0[VlWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV\qfnBjUUN3ME2yMlY1OTR\|IN88US=>	MWXTRW5ITVJ?
NCI-H510A	NFrtUJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NG\jSYpKSzVyPUKuOlQ1OjZizszN	MYXTRW5ITVJ?
BPH-1	M4rmfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGHa[phKSzVyPUKuOlU5PSEQvF2=	M1HPXXNCVkeHUh?=
M14	NIXWWXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWjJR\|UxRTJwNk[5PVMh\|ryP	MYHTRW5ITVJ?
G-402	M4i4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVHGN5VqUUN3ME2yMlcxPDVzIN88US=>	NEXkVlNUSU6JRWK=
AsPC-1	MnzTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVLJR\|UxRTJwN{GxO{DPxE1?	M{HHSHNCVkeHUh?=
NB12	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkP0TWM2OD1{LkexO\|Eh\|ryP	M4mxU3NCVkeHUh?=
SK-HEP-1	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3\ZRWlEPTB;Mj63OFM6OSEQvF2=	NHH6XG1USU6JRWK=
U-266	MlHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml2wTWM2OD1{Lke3NVIyKM7:TR?=	M2PzOnNCVkeHUh?=
AM-38	NIDQU4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXvJR\|UxRTJwN{ezOVUh\|ryP	MoS5V2FPT0WU
PC-14	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkPLTWM2OD1{LkiwOVEh\|ryP	MmG3V2FPT0WU
EGI-1	M3nYT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2DiWGlEPTB;Mj64NVc1OyEQvF2=	M1z3OHNCVkeHUh?=
LS-411N	M4L0UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXHXcZFDUUN3ME2yMlgzOzNizszN	MmDQV2FPT0WU
BFTC-905	M2rY[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUjJR\|UxRTJwOEW1NlMh\|ryP	Mn;QV2FPT0WU
CaR-1	NYLSemJrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVfJR\|UxRTJwOE[g{txO	M{H3cXNCVkeHUh?=
NCI-H292	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXrJR\|UxRTJwOE[1PVYh\|ryP	M{D3e3NCVkeHUh?=
8305C	NIHyToZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NITMOodKSzVyPUKuPFY3PDVizszN	M{[1dnNCVkeHUh?=
SNU-449	NULWXYhXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYHJR\|UxRTJwOEmxPFIh\|ryP	M4DIO3NCVkeHUh?=
LCLC-103H	Ml3rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWPJR\|UxRTJwOUC0N\|gh\|ryP	MWnTRW5ITVJ?
SW1573	Mom5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlLhTWM2OD1{Lkm2NFgzKM7:TR?=	M4nvVXNCVkeHUh?=
MLMA	NGHFUVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWfjOXZGUUN3ME2yMlk3PzF5IN88US=>	NELxVFdUSU6JRWK=
NCI-H1355	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnLGTWM2OD1\|LkCwO\|k3KM7:TR?=	NETveJdUSU6JRWK=
RMG-I	M1q0cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXLJR\|UxRTNwMEK1PVIh\|ryP	M2TjS3NCVkeHUh?=
BB65-RCC	M37rSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3m2WWlEPTB;Mz6wN\|MyPCEQvF2=	NETObGxUSU6JRWK=
PC-3	MoPBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkTKTWM2OD1\|LkCzPFc1KM7:TR?=	NFjmWVlUSU6JRWK=
SF268	M2P2d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEPxfYNKSzVyPUOuNFQ2OjNizszN	M3TQcXNCVkeHUh?=
NCI-H810	NWnPO2NIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1HRWGlEPTB;Mz6wOFgzOyEQvF2=	NX\sTGQ4W0GQR1XS
MEG-01	M1n3NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXGzVYs4UUN3ME2zMlA3OTZ2IN88US=>	NFOxNGVUSU6JRWK=
SW13	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYfJR\|UxRTNwMEe4OFch\|ryP	NIDCOWRUSU6JRWK=
RH-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGD6e2xKSzVyPUOuNVAzPzhizszN	Ml\wV2FPT0WU
GT3TKB	NFuz[5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnT1TWM2OD1\|LkGxNlg{KM7:TR?=	M2jQPXNCVkeHUh?=
TK10	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUDJR\|UxRTNwMUO3NlQh\|ryP	MVjTRW5ITVJ?
T-24	NXP6bHVtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3K0S2lEPTB;Mz6xOVA4KM7:TR?=	NUTW[oF[W0GQR1XS
A498	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1TDe2lEPTB;Mz6yNFg4OSEQvF2=	MXTTRW5ITVJ?
GR-ST	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV;JR\|UxRTNwMkKxN\|kh\|ryP	MmXMV2FPT0WU
LB2518-MEL	MmTLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFjLfYRKSzVyPUOuNlI{QThizszN	NH7Md4pUSU6JRWK=
T47D	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXrMNGFVUUN3ME2zMlI{PjJ5IN88US=>	MWTTRW5ITVJ?
NCI-H1651	NVj6c\|VST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYLJR\|UxRTNwMkS2OFQh\|ryP	MVjTRW5ITVJ?
EC-GI-10	MknZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV\GOVB2UUN3ME2zMlI3OTV\|IN88US=>	NH3WSY9USU6JRWK=
HT-29	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3\jb2lEPTB;Mz6yOlYyPCEQvF2=	NGT4XlBUSU6JRWK=
GI-ME-N	NHfZ[phIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHzlbXBKSzVyPUOuNlk2OTFizszN	M4nCOHNCVkeHUh?=
SW756	Mn:5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWrJR\|UxRTNwMkm2Nlkh\|ryP	MXrTRW5ITVJ?
RKO	MoLoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYHJR\|UxRTNwM{C3OVch\|ryP	M3L3dXNCVkeHUh?=
NCI-H1563	MlrZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGrGcpdKSzVyPUOuN\|MxOThizszN	NXrqeWR7W0GQR1XS
DJM-1	NF7HO49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXj3UnJ2UUN3ME2zMlM4Pjd2IN88US=>	MljqV2FPT0WU
L-428	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGDNR5FKSzVyPUOuOFAxPDVizszN	NYOyUFdFW0GQR1XS
NCI-H2122	NH\kZY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTNwNEGzNVIh\|ryP	MUjTRW5ITVJ?
Ca-Ski	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1XvW2lEPTB;Mz60OVQ{KM7:TR?=	MlTtV2FPT0WU
639-V	M2LnbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUXVNXd5UUN3ME2zMlQ3ODV5IN88US=>	NULKN4lFW0GQR1XS
SW1116	M4LwWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX\PWYdGUUN3ME2zMlQ3OjZ7IN88US=>	NYXKdZRkW0GQR1XS
DMS-114	MorzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NX;FeYtJUUN3ME2zMlQ4ODZ4IN88US=>	NW\a[VR3W0GQR1XS
MZ2-MEL	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIfhc\|lKSzVyPUOuOFc3QDFizszN	M{DBbnNCVkeHUh?=
COLO-829	MmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2rLemlEPTB;Mz61NFA4OyEQvF2=	Mme2V2FPT0WU
J82	NXvXcYI1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYLhNYwyUUN3ME2zMlUxPTdizszN	NFv0TJNUSU6JRWK=
EW-13	MoO4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHrDV4RKSzVyPUOuOVI2OSEQvF2=	NU\GZYdWW0GQR1XS
RXF393	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUnIXWVEUUN3ME2zMlU{Ojl2IN88US=>	M3XQZnNCVkeHUh?=
CAL-62	NHjBRoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYD4dXpVUUN3ME2zMlU1PTF2IN88US=>	MoG1V2FPT0WU
OCUB-M	Ml7jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYDJR\|UxRTNwNUS2OlUh\|ryP	Mom4V2FPT0WU
BT-474	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{jscmlEPTB;Mz62N\|MyKM7:TR?=	MWPTRW5ITVJ?
KYSE-180	M1H2bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHzPRpVKSzVyPUOuOlM{PzJizszN	M2\MRXNCVkeHUh?=
NCI-H650	NF3qe21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWezPGxQUUN3ME2zMlY1Ojh5IN88US=>	M4DXNnNCVkeHUh?=
Detroit562	M2rvZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4XjeGlEPTB;Mz62OVAzOiEQvF2=	M{PZT3NCVkeHUh?=
SW48	NYPwW2prT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWHRVpB7UUN3ME2zMlY2PjV5IN88US=>	NIK4RXVUSU6JRWK=
KYSE-450	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV;JR\|UxRTNwNki1PFIh\|ryP	NXTMZVdVW0GQR1XS
KYSE-510	M4\kNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkHFTWM2OD1\|LkeyNVgyKM7:TR?=	NXrRN\|JDW0GQR1XS
GP5d	M2S5ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUjhZXIxUUN3ME2zMlczQTVizszN	MUnTRW5ITVJ?
RPMI-7951	NGHZfpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVnJR\|UxRTNwN{S3NlMh\|ryP	MljUV2FPT0WU
Becker	NEjJfIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXfoNldwUUN3ME2zMlc2ODF{IN88US=>	Ml65V2FPT0WU
WM-115	NX7yTnhVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIfJWHRKSzVyPUOuO\|gyQTVizszN	NVn3OJNlW0GQR1XS
G-401	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWTnZllqUUN3ME2zMlc6ODh3IN88US=>	M4rTd3NCVkeHUh?=
PANC-08-13	NFT5W4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{O3[mlEPTB;Mz63PVYxOiEQvF2=	NXryTFk5W0GQR1XS
SW982	NVPRfIF6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmqwTWM2OD1\|LkiwOVUyKM7:TR?=	NG\mR3RUSU6JRWK=
D-263MG	NEXZdXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkPBTWM2OD1\|LkiyNFUyKM7:TR?=	MX\TRW5ITVJ?
KM-H2	NHjFN2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MULJR\|UxRTNwOEK2NlQh\|ryP	M2\DbHNCVkeHUh?=
SK-MEL-3	NWCzOmZYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mor0TWM2OD1\|LkiyPFQyKM7:TR?=	NF20R2VUSU6JRWK=
NCI-H1581	M4G5PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXXJR\|UxRTNwOES0PFgh\|ryP	Mn7KV2FPT0WU
LS-123	MnH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGLaW5hKSzVyPUOuPFc6ODlizszN	NWnyfI9IW0GQR1XS
CAKI-1	NHu5SHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2XNV2lEPTB;Mz64PVA2OiEQvF2=	NEjVPW1USU6JRWK=
MEL-JUSO	NH7pRZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIXxZ4hKSzVyPUOuPFkyPTNizszN	M4DDWnNCVkeHUh?=
HCE-4	NEDZcJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3LvUmlEPTB;Mz65NVY3OyEQvF2=	NELE[nVUSU6JRWK=
TE-10	NUXYOJRzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFzkPWtKSzVyPUOuPVIxOSEQvF2=	M{PFfHNCVkeHUh?=
OVCAR-4	NIPsbmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFLPT49KSzVyPUOuPVI5QDlizszN	NWXRbpdUW0GQR1XS
ETK-1	MoKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlO2TWM2OD1\|Lkm0OlM2KM7:TR?=	MWLTRW5ITVJ?
A2780	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mnv3TWM2OD12LkC1PVY3KM7:TR?=	MUPTRW5ITVJ?
LU-65	NFvXeXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFfWfoRKSzVyPUSuNFc3OzNizszN	NUDMeHQyW0GQR1XS
BHY	M{P4WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVTJR\|UxRTRwMUK0PVUh\|ryP	NUDOR29{W0GQR1XS
COR-L105	NVTacIY6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlzzTWM2OD12LkGzNFUyKM7:TR?=	NF:xSWpUSU6JRWK=
CAL-12T	Mn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHHhU\|hKSzVyPUSuNVMyODNizszN	M2jMWnNCVkeHUh?=
SCH	NEHiOGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIrPXXBKSzVyPUSuNVU4PDNizszN	M2[wR3NCVkeHUh?=
CW-2	MlW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2PaSWlEPTB;ND6xPVAxOSEQvF2=	MX\TRW5ITVJ?
HCC1806	NWLLSVgzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHq0cohKSzVyPUSuNlA{OTJizszN	M2rNUnNCVkeHUh?=
KP-N-YN	NFjETJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYf4SYFTUUN3ME20MlIxQTJ5IN88US=>	MV\TRW5ITVJ?
T98G	M17zSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2nMdGlEPTB;ND6yNlE2PyEQvF2=	NF7vRlZUSU6JRWK=
CAL-54	MofLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUTaNWdjUUN3ME20MlIzOzhzIN88US=>	MXXTRW5ITVJ?
CAL-33	M2fOfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYfKN4F4UUN3ME20MlI{ODZ2IN88US=>	MkPuV2FPT0WU
SNU-C2B	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFq4e3pKSzVyPUSuNlQ4PjlizszN	MmrMV2FPT0WU
NUGC-3	NGjvb2pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTRwMkW1NFUh\|ryP	Mk\QV2FPT0WU
DOK	Mlj6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHHqSotKSzVyPUSuNlY2QTNizszN	MnTzV2FPT0WU
MMAC-SF	Ml\KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkS2TWM2OD12LkK2PFU6KM7:TR?=	NF[yW2ZUSU6JRWK=
KYSE-70	M1L5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoW4TWM2OD12LkK5N\|Qh\|ryP	MmPwV2FPT0WU
A204	M{nCbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmHtTWM2OD12LkO1PFA{KM7:TR?=	NX\wXJNuW0GQR1XS
SCC-25	NG\HeHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1jpXWlEPTB;ND6zOVgyQSEQvF2=	MYDTRW5ITVJ?
EPLC-272H	NE\pOIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mn7pTWM2OD12LkO4PVUh\|ryP	MoXyV2FPT0WU
CAL-120	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoDRTWM2OD12LkO4PVkzKM7:TR?=	NWnTbVZvW0GQR1XS
LS-513	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWjtTFBpUUN3ME20MlQzOTl6IN88US=>	M37CNXNCVkeHUh?=
CAPAN-1	M{Lud2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoLLTWM2OD12LkSyN\|gzKM7:TR?=	NW\EZWNNW0GQR1XS
ESS-1	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkPqTWM2OD12LkSyO\|I1KM7:TR?=	Mlr1V2FPT0WU
GMS-10	NHXDW4lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1jGV2lEPTB;ND60NlgyQSEQvF2=	MYDTRW5ITVJ?
NCI-N87	NIDESolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFPvNZJKSzVyPUSuOVA5PjhizszN	M4\SSHNCVkeHUh?=
HMV-II	Mmr1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmTmTWM2OD12LkWxO\|Mh\|ryP	NF;TTlJUSU6JRWK=
COLO-741	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHHGbZdKSzVyPUSuOVU6QTRizszN	M3K3NnNCVkeHUh?=
MKN45	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHXvXHBKSzVyPUSuOVc4OzJizszN	M{nsOXNCVkeHUh?=
OAW-28	MmTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIr4bIFKSzVyPUSuOVg{QThizszN	M2TvU3NCVkeHUh?=
OCI-AML2	NIC4VHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIHQV3lKSzVyPUSuOlUzOzhizszN	M{jUSHNCVkeHUh?=
MDA-MB-231	NVq1Npl4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVLJR\|UxRTRwN{CyOFMh\|ryP	MYHTRW5ITVJ?
NCI-H1648	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NI\iOmZKSzVyPUSuO\|IzPzNizszN	NW\TNXdlW0GQR1XS
NCI-H1792	MnfhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1v3b2lEPTB;ND63OlExPyEQvF2=	MYnTRW5ITVJ?
GCIY	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWXJR\|UxRTRwN{e0NlQh\|ryP	MnjtV2FPT0WU
Hs-578-T	NHTDVGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnW1TWM2OD12Lke3OlU2KM7:TR?=	MoLUV2FPT0WU
SW962	NH;jZWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEGySlBKSzVyPUSuO\|gxOTFizszN	MlT1V2FPT0WU
NCI-H630	M1HvTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHLqPHdKSzVyPUSuO\|gxQDFizszN	NHvvcHBUSU6JRWK=
786-0	M1u4c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkHyTWM2OD12Lke4O\|c{KM7:TR?=	NGfzTHNUSU6JRWK=
FTC-133	NED2fmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF;PUo5KSzVyPUSuO\|kzPjNizszN	NHjiZXZUSU6JRWK=
BT-20	NEnu[5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NX3lfIQxUUN3ME20Mlc6PDJ7IN88US=>	NU\BWJRxW0GQR1XS
Mewo	NWPuZ\|lpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYfJR\|UxRTRwOEG3OFch\|ryP	NVmwNm9yW0GQR1XS
SW780	M{LLS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF7Qb4NKSzVyPUSuPFU4PjZizszN	NWHhS4FlW0GQR1XS
OE33	NFexeHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEDPOHhKSzVyPUSuPFc4OTNizszN	M4nqNHNCVkeHUh?=
HCC1569	M1jzWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHvaXnhKSzVyPUSuPFg1PThizszN	MVjTRW5ITVJ?
TE-6	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NI\ZZlhKSzVyPUSuPVM6PzdizszN	M1W3cnNCVkeHUh?=
SK-N-FI	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1PVemlEPTB;ND65OFQzOSEQvF2=	NEPjZ\|VUSU6JRWK=
PANC-03-27	M2n6VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFHZO2VKSzVyPUSuPVk6PjJizszN	NF6zbopUSU6JRWK=
MCF7	NIToVnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4LlTmlEPTB;NT6wNFc{QCEQvF2=	NFftbmFUSU6JRWK=
UACC-257	NX75XnR4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWDoTlJnUUN3ME21MlAzQDR3IN88US=>	NF\wZVJUSU6JRWK=
SW1088	M3\jbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYPqXpJxUUN3ME21MlAzQTR2IN88US=>	M4\WcXNCVkeHUh?=
A704	NVrld2dST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWTJR\|UxRTVwMEOwOkDPxE1?	M37obXNCVkeHUh?=
A2058	M2Cyc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGmyb5RKSzVyPUWuNFU6ODhizszN	NFPYXVNUSU6JRWK=
Calu-3	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUjJR\|UxRTVwME[0OVIh\|ryP	NEnpVZVUSU6JRWK=
RERF-LC-MS	M1HOSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlnvTWM2OD13LkC2PVA{KM7:TR?=	Mof6V2FPT0WU
AU565	M3Tmfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVHsTXl7UUN3ME21MlA6PzB{IN88US=>	M3;uVXNCVkeHUh?=
DMS-79	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXvmboJLUUN3ME21MlE{QDh\|IN88US=>	MmDMV2FPT0WU
DK-MG	NEDDT45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXH4TIFvUUN3ME21MlE5PDN6IN88US=>	MlmyV2FPT0WU
HuCCT1	MojES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4rCV2lEPTB;NT6yN\|g2PiEQvF2=	M3L5eXNCVkeHUh?=
HT-144	NELQO3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXLxT3VnUUN3ME21MlI1QTh5IN88US=>	MX\TRW5ITVJ?
M059J	NFHwTlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXPJR\|UxRTVwMkW3OkDPxE1?	NF7NNYdUSU6JRWK=
COLO-792	NEPycWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4Xzc2lEPTB;NT6yOlM2PiEQvF2=	NH61endUSU6JRWK=
SF539	NWTRdXlxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkiwTWM2OD13LkK2OlMzKM7:TR?=	MnP4V2FPT0WU
SK-UT-1	M1TjcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWf3fIM3UUN3ME21MlI4PzVzIN88US=>	NFTn[nlUSU6JRWK=
NCI-H1703	NVzCV3F2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYPJR\|UxRTVwM{W4NlYh\|ryP	M{LUdHNCVkeHUh?=
SW837	NXzINVZNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWf3c3czUUN3ME21MlM4QDd6IN88US=>	M2DsOXNCVkeHUh?=
U251	NFzvS2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYfJR\|UxRTVwM{mwPVYh\|ryP	NGGzdHhUSU6JRWK=
SW1710	NUTpT\|VmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF\oR2VKSzVyPUWuOFE2PTRizszN	MknDV2FPT0WU
NCI-H1299

研究领域